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The stability of our genome is constantly challenged by several genotoxic threats. DNA 
double-strand breaks (DSBs) are the most dangerous DNA lesions that, if not repaired, can 
lead to cancer initiation and progression and/or ageing. These detrimental consequences can 
only be avoided if cells promptly recognize the lesions and signal their presence, thus 
promoting either efficient repair and transient cell cycle arrest or cell death and cellular 
senescence. This is the role of the DNA damage response (DDR) proteins and the newly 
identified damage-induced non coding RNAs. We recently discovered that RNA polymerase 
II is recruited to DSBs and synthetizes damage-induced non-coding RNAs (dilncRNAs). 
DROSHA- and DICER-mediated processing of dilncRNAs generates small RNA species, 
named DNA damage response RNA (DDRNAs) (Francia, 2012), that localize to DSBs via 
pairing with dilncRNAs and promote DDR signaling (Michelini et al., in press). Similar 
small non-coding RNA species discovered in plants are involved in DNA repair by 
homologous recombination (HR) (Wei, 2012, Gao, 2014, Wang, 2016). In line with these 
results, I report that transcriptional inhibition impairs recruitment of the HR proteins 
BRCA1, BRCA2, and RAD51 to DSBs, while partially promoting DNA end resection. 
Moreover, I show DNA:RNA hybrids accumulation at DSBs in mammalian cells by both 
DRIP analyses and imaging techniques. Damage-induced DNA:RNA hybrids form upon the 
hybridization of RNA species, likely dilncRNAs, to the resected DSBs DNA ends generated 
during the S/G2 cell cycle phase. I also report that purified recombinant BRCA1 binds 
DNA:RNA hybrids in vitro; moreover, DNA:RNA hybrids in vivo contribute to BRCA1 
recruitment to DSBs. Consistent with the need to tightly regulate DNA:RNA hybrid levels, 
I demonstrate that RNase H2, the major RNase H activity in mammalian nuclei, is recruited 
to DSBs through direct interaction with RAD51. In summary, I report for the first time that 
DNA:RNA hybrids accumulate at DSBs in mammalian cells in a cell-cycle- and DNA end 
resection-depended way. At DSBs, BRCA1 directly recognizes DNA:RNA hybrids and 
likely controls their turn-over by mediating the recruitment of RNase H2 via RAD51.  
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1.1 DNA damage: from signaling to repair 
1.1.1 Types of DNA damage 
It has been estimated that every day the stability of our genome is challenged by thousands 
of lesions (Lindahl and Barnes, 2000). In the majority of the cases, these lesions are 
efficiently repaired, while their inefficient repair has been associated to malignant 
transformation and cancer progression (Hanahan and Weinberg, 2011).  
Genotoxic stimuli mainly target the nitrogen bases of the DNA, causing their loss or 
modification. However, they may also severely challenge the stability of our genome by 
breaking simultaneously the sugar-phosphate backbones of the two complementary DNA 
strands, generating a DNA double-strand break (DSB). A DSB is the most toxic DNA lesion 
since its inaccurate repair not only results in insertions or deletions, but can also cause gross 
genetic rearrangements, such as translocations, that are common in many cancers (Jackson 
and Bartek, 2009). This is the case, for example, for Burkitts Lymphoma, where a 
translocation event juxtaposes the strong immunoglobulin heavy chain promoter to the 
oncogene c-myc, causing aberrant expression of the oncogene, thus leading to cancer 
initiation and progression (Taub et al., 1982). In addition to cancer, DSBs have been linked 
to developmental, neurological, and immunological disorders (Jackson and Bartek, 2009).  
DSBs may be generated upon exposure to several exogenous factors, including chemicals, 
or ionizing radiation (IR), for instance generated during radiotherapy and chemotherapy for 
medical treatments. Additionally, DSBs may be caused by endogenous free-radical oxygen 
species produced during cellular metabolism, or may arise during several other physiological 
processes, including DNA replication, transcription, or when these two processes collide 
(Aguilera and Gaillard, 2014). In addition to being a by-product of cellular processes, DSBs 
formation may be a key step of other specialized processes. Indeed, scheduled DSBs are 
generated during class switch and V(D)J recombination, two mechanisms required for the 
antibody repertoire diversification in the immune system (Soulas-Sprauel et al., 2007), and 
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meiotic recombination (Neale and Keeney, 2006).  
1.1.2 The DNA damage response (DDR) 
When our genome is damaged, the cell orchestrates a cellular response known as DNA 
damage response (DDR), that senses the damage, signals its presence, coordinates the repair, 
and finally leads to the activation of checkpoint responses that slow down or arrest cell-cycle 
progression, until the damage has been repaired (Ciccia and Elledge, 2010, d'Adda di 
Fagagna, 2008).  
In order to activate DDR, the cell should be alerted of the presence of the DNA lesions. This 
is the job of the sensor proteins, Meiotic Recombination 11 (MRE11)/ Nijmegen breakage 
syndrome 1 (NBS1)/ RAD50 (MRN) and Replication Protein A (RPA), that recognize, 
respectively, exposed DNA ends or ssDNA stretches generated either upon DSBs end 
resection or replication stress (d'Adda di Fagagna, 2008).  
MRN is a trimeric protein complex that associates with DNA through its globular “head”, 
composed of MRE11 dimer and two RAD50 ATP-binding cassette (ABC) ATPase domains, 
and recruits ATM through the flexible adapter NBS1 (Williams et al., 2010).  Once recruited 
to DSBs, ATM gets activated via a not yet fully defined mechanism that determines the 
transition from a multimeric inactive to a monomeric active form (Blackford and Jackson, 
2017).  
RPA is a heterotrimeric complex composed of the RPA70, RPA32 and RPA14 subunits, 
which binds to DNA through the oligonucleotide/oligosaccharide (OB) binding domains of 
the RPA70 and the RPA32 subunits (Zou and Elledge, 2003). RPA recruits the ATR kinase 
via the ATR interacting protein (ATRIP) and, through the RAD17/RCF complex, facilitates 
the loading of the RAD9–HUS1–RAD1 (9–1–1) clamp complex on ssDNA-dsDNA 
junctions. The 9-1-1 complex, in turn, recruits the topoisomerase II binding protein 1 
(TopBP1) that binds the ATR-ATRIP complex and leads to ATR activation (Zou and 
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Elledge, 2003). Recently, a role for PRP19, an E3 ubiquitin ligase involved in pre-mRNA 
splicing, in ATR-ATRIP accumulation and signaling has been reported (Polo et al., 2012). 
ATM and ATR are members of the phosphatidylinositol 3-kinase-like family of 
serine/threonine protein kinases (PIK kinases), which phosphorylate their substrates on a 
serine or threonine followed by glutamine, the S/TQ motif (Blackford and Jackson, 2017). 
The histone variant H2AX is one of the major targets of ATM and ATR, as well as of the 
PIK kinase DNA-PK. DNA damage induced phosphorylation of H2AX on serine 139 
(named γH2AX) is recognized by DNA-damage checkpoint 1 (MDC1), which interacts with 
and mediates additional loading of the MRN complex. This, in turn, fuels ATM activation 
and H2AX phosphorylation, thus generating a positive feedback loop that strongly amplifies 
DDR signaling and results in the spreading of γH2AX for several kilobases around the DSB, 
generating a sort of “molecular velcro” for the retention of DDR proteins (Rogakou et al., 
1999, d'Adda di Fagagna, 2008). This is a key point in DDR activation since the initial 
recruitment of DDR proteins through direct recognition of DNA ends (primary recruitment) 
is reinforced by a more complicated γH2AX dependent recruitment (secondary recruitment) 
(Celeste et al., 2003). Among the others, MDC1 mediates the recruitment of the E3 ubiquitin 
ligase RNF8 that, together with RNF168, mediates ubiquitylation of H2AX that is crucial 
for recruitment of mediator proteins, such as BRCA1 and 53BP1(Bekker-Jensen and 
Mailand, 2010). In addition to phosphorylation and ubiquitylation events, other reversible 
post-translational modifications like sumoylation and metylation are essential for DDR 
activation (Jackson and Durocher, 2013).   
Additional major targets of ATM and ATR phosphorylation are the downstream protein 
kinases CHK2 and CHK1, respectively (Bekker-Jensen and Mailand, 2010). Activated 
CHK1 and CHK2 diffuse in the nucleoplasm, spreading the signal by phosphorylating their 
substrates throughout the nuclear space, and ultimately leading to the activation of p53 and 
the CDC25 phosphatases. At this point, DDR activation and cell cycle progression becomes 
strongly intertwined. On one hand, DNA damage dependent phosphorylation of the CDC25 
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phosphatases leads to inactivation of the CDK-Cyclin complexes that are responsible for the 
progression throughout the cell-cycle phases. On the other hand, cell-cycle arrest is obtained 
by p53-mediated transcription of the CDK1 inhibitor p21 (Branzei and Foiani, 2008). DNA 
damage-induced cell-cycle arrest is usually transient and cells restart proliferating normally 
once damage has been repaired. However, when the damage is not repaired cells may 
undergo apoptosis or enter a prolonged DDR-induced cell-cycle arrest known as cellular 
senescence (d'Adda di Fagagna, 2008). 
1.1.2.1 The multiple roles of BRCA1 in the DDR 
The breast and ovarian cancer type 1 susceptibility protein (BRCA1) is a protein with a key 
role in the maintenance of genome stability since it coordinates various aspects of the DNA 
damage response, from cell cycle activation to homologous recombination (HR)-mediated 
DSB repair (Huen et al., 2010). BRCA1 and breast and ovarian cancer type 2 susceptibility 
(BRCA2) genes are the most frequently mutated genes in breast and ovarian cancer 
(Venkitaraman, 2002) and recently-developed drugs exploit their key function in DNA 
repair to selectively target cancer cells (Polyak and Garber, 2011).   
At the protein level, BRCA1 interacts with BARD1, through its N-terminal RING domain, 
forming a constitutive heterodimer with E3 ubiquitin ligase activity (Wu et al., 1996). 
Although the role of BRCA1-BARD1 mediated ubiquitylation in DDR is still poorly 
understood, it has been shown that BRCA1-mediated ubiquitylation of H2A at 
pericentromeric heterochromatin represses the expression of satellite DNA, thus promoting 
genome stability (Zhu et al., 2011). 
The BRCT domain located at BRCA1 C-terminus, mediates the mutually exclusive 
interaction of the BRCA1-BARD1 heterodimer with phosphorylated ABRAXAS, BACH1, 
or CtIP, forming three different complexes, respectively known as BRCA1-A, BRCA1-B, 
and BRCA1-C (Huen et al., 2010). A fourth BRCA1 (BRCA1-D) complex is generated by 
interaction with BRCA2 and its associated partners PALB2 and RAD51 (Huen et al., 2010) 
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(figure 1). BRCA1-A complex is composed of RAP80, ABRAXAS, BRCC36, BRCC45 
(also known as BRE), and mediator of RAP80 interactions and targeting subunit of 40 kDa 
(MERIT40). This complex mainly targets BRCA1 to DSBs through RAP80 interaction with 
the ubiquitin chains generated by the E3 ubiquitin ligases RNF8 and RNF168 (Mailand et 
al., 2007). However, an earlier H2AX independent (Celeste et al., 2003) and BARD1- and 
PARylation- dependent (Li and Yu, 2013) recruitment has also been observed, supporting 
the pleiotropic roles of BRCA1 in different complexes at DSBs. The main function of the 
BRCA1-A complex is the activation of the G2–M checkpoint and the inhibition of DNA end 
resection (Hu et al., 2011). 
BRCA1–B complex contains TopBP1 and the BRCA1-interacting protein carboxy-terminal 
helicase 1 (BACH1) and it has a role mainly in DNA replication and S phase checkpoint 
activation (Huen et al., 2010). 
In the BRCA1-C complex BRCA1 interacts with MRN and CtIP. CDK-dependent S327 
phosphorylation of CtIP is required for its interaction with BRCA1 (Huertas and Jackson, 
2009, Yu and Chen, 2004). This interaction, although dispensable for DNA end resection 
(Reczek et al., 2013, Polato et al., 2014), increases the efficiency of the process (Cruz-Garcia 
et al., 2014). Although BRCA1 does not contribute directly to DNA end resection, it has a 
fundamental role in contrasting its inhibition by resection blockers, including 53BP1, RIF1, 
and PTIP (Hustedt and Durocher, 2016), as discussed later. Indeed, in the absence of 
resection barriers (for example, in the case of 53BP1 depletion), CtIP mediated resection is 
possible even in the absence of BRCA1 (Polato et al., 2014).  
The BRCA1-D complex is composed of BRCA1, BRCA2, PALB2, and RAD51 and it has 
a key function in HR since it mediates the loading of RAD51 on the RPA-covered ssDNA 
stretches generated upon resection of broken DNA ends. PALB2 bridges the interaction 
between the coiled-coiled domain of BRCA1 and BRCA2. BRCA2 interacts with RAD51 
through different domains, as discussed later, and mediates its loading on resected DNA 
ends (Prakash et al., 2015).   
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adapted from (Savage and Harkin, 2015) 
Figure 1: BRCA1 complexes and their role in DNA damage signaling and repair 
BRCA1 associates with MRN and CtIP in the BRCA1-C complex to promote DNA end resection manly by 
displacing the resection “blockers” such as 53BP1. The BRCA1-B complex, composed of BACH1 and 
TopBP1, promotes, together with BRCA1-C, extensive resection and the consequent activation of the intra-S 
checkpoint. The BRCA1–A complex is composed of RAP80, ABRAXAS, BRCC36, BRCC45, and MERIT40. 
Trough RAP80, BRCA1-A is recruited to flanking chromatin where prevents DNA end resection. Moreover, 
BRCA1-A participates to the activation of the G2/M checkpoint. BRCA1, PALB2, BRCA2, and RAD51 form 
the BRCA1-D complex, which facilitates the exchange of RPA with RAD51 on the ssDNA ends generated 
upon DNA end resection. ssDNA-RAD51-mediated homology search and invasion allows the synthesis of the 
missing part of the broken DNA end to allow HR completion.  
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1.1.3 DSB repair pathways 
DSBs are the most toxic lesions that, if not properly repaired, can lead to mutations, 
chromosomal rearrangements and genome instability (Jackson and Bartek, 2009). In order 
to efficiently repair DSBs, cells have evolved two main pathways that can either use 
homologous sequences as templates for repair (homology-directed recombination, HDR) 
(figure 2b) or not (non homologous end joining, NHEJ) (figure 2a). While NHEJ is active 
throughout the entire cell cycle, the availability of the template sister chromatid during the 
S and G2 phases restricts HDR to these cell-cycle phases. A key factor in the choice between 
NHEJ and HDR is the licensing of DNA-end resection (Chapman et al., 2012b). 
1.1.3.1 NHEJ 
NHEJ is the faster way to repair a DSB since it simply rejoins severed DNA ends, with 
partial or no processing of them (Chang et al., 2017). The initial step of the classical NHEJ 
pathway (c-NHEJ) is the loading on the broken ends of the Ku70/Ku80 complex, which 
tethers DNA ends together and mediates the recruitment and activation of other key proteins 
with endonuclease, polymerase and DNA ligase activities. Once DSBs have been recognized 
by the Ku70/80 complex, compatible DNA ends can be directly rejoined by DNA ligase IV, 
in association with its binding partners X-ray repair cross-complementing protein 4 
(XRCC4) and XRCC4-like factor (XLF) (figure 2a). However, 20-50% of IR-induced DSBs 
need to be processed prior to ligation (Riballo et al., 2004, Kurosawa et al., 2008). In this 
case, DNA-bound Ku70/80 facilitates the recruitment of the DNA-dependent protein kinase 
catalytic subunit (DNA-PKcs), which binds both to DNA and to Ku70/80, and mediates its 
activation. Active DNA-PKcs then contributes to the phosphorylation of several NHEJ 
factors, including Ku70, Ku80, Artemis, XRCC4, XLF, and LIG4, as well as the histone 
variant H2AX at DNA breaks (An et al., 2010). Once activated by DNA-PKcs, the nuclease 
ARTEMIS processes DSBs making the DNA ends compatible for the subsequent ligation 
step (Chang et al., 2017). 
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When micro-homology sequences flanking the DSB are present, an alternative NHEJ (a-
NHEJ) pathway, also known as micro-homology-mediated end joining (MMEJ), repairs 
DSBs through the coordinated action of DNA ligase III, XRCC1, and PARP1 (Chang et al., 
2017).   
 
adapted from (Chowdhury et al., 2013) 
Figure 2: DSB repair pathways  
A DSB can be repaired by either NHEJ (a) throughout the cell-cycle phases or HDR-dependent pathways (b) 
during S/G2 phase. In NHEJ-mediated repair, the Ku70/80 heterodimer binds to the broken DNA ends and 
recruits the catalytic subunit of DNA-PK (DNA-PKcs) and 53BP1. DNA-PKcs activation favors Artemis-
mediated processing of DNA ends making them suitable for the ligation mediated by the XRCC4/DNA ligase 
IV complex (a). HDR starts with the resection of the broken DNA ends to generate ssDNA stretches covered 
by RPA. DNA end resection is initiated by the MRN complex, in the presence of CtIP and it is extended by 
EXO1 and DNA2/BLM; BRCA1, although not strictly necessary, increases the speed of the process. Next, the 
BRCA2/PALB2/BRCA1 complex promotes the replacement of RPA with RAD51 on the ssDNA ends. RAD51 
nucleofilaments invade the homologous DNA sequences and the invading DNA is extended by DNA 
polymerase δ and ligated. Once the DNA intermediates structures have been resolved, an exact copy of the 
original template sequence has replaced the damaged DNA at the DSB site (b).   
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1.1.3.2 HDR 
DNA end resection is a biphasic process. An initial short-tract resection is mediated by the 
coordinated action of CtIP and the MRE11 subunit of the MRN complex, which has both 
endo- and exo-nuclease activities. The subsequent long-tract resection requires the 
additional action of exonuclease 1 (EXO1). The observation that the exo-nucleolytic activity 
of MRE11 is 3’-5’ oriented has been difficult to reconcile with the generation of 3’-
protruding ssDNA overhangs. Only recently, a model explaining this apparent controversy 
has been generated (figure 3). According to this model, DNA end resection starts with 
MRE11 endo-nucleolytic cleavage of dsDNA few nucleotides away from the DNA end, an 
event stimulated by CtIP. After endo-nucleolytic cleavage, resection proceeds bi-
directionally, with MRE11 and EXO1 respectively resecting in 3ʹ–5ʹ direction and 5ʹ–3ʹ 
resection (Chapman et al., 2012b). The ssDNA filaments generated upon resection are 
immediately bound by RPA, which protects the ssDNA and avoids the formation of ssDNA  
secondary structures. 
 
                                    adapted from (Chapman et al., 2012b) 
Figure 3: Mechanism of DNA end resection  
Mre11 endonuclease nicks the DNA strand few nucleotides away from the DSB, initiating bi-directional 
resection dependent on the exonuclease activity of Mre11 (3’ to 5’ oriented) and Exo1 (5’ to 3’ oriented). This 
process is facilitated by CtIP and results in the eviction of Ku from the DNA ends  
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When extensive resection of the broken DNA ends exposes homologous sequences flanking 
the DSB, the recombinase RAD52 mediates a process known as single-strand annealing 
(SSA), that anneals the homologous sequences leading to the loss of the genetic information 
contained on the resected DNA ends. Long range DNA end resection and the associated SSA 
pathway are inhibited by 53BP1 (Ochs et al., 2016). Recently, an additional role for RAD52 
in mediating inverse strand exchange with RNA molecules has been described (Keskin et 
al., 2014, Mazina et al., 2017). However, the observation that in mammalian cells RAD52 
depletion does not affect survival upon IR (Rijkers et al., 1998) and is only lethal in 
combination with depletion of other HR proteins (Lok et al., 2013), suggests that the 
RAD52-mediated mechanisms may act as a backup in the absence of canonical HR repair 
pathway.  
More frequently, HDR based mechanism uses homologous sequences located on the sister 
chromatids to template repair of either one-ended DSBs, generated by broken replication 
forks (Verma and Greenberg, 2016), or two-ended DSBs, in a process known as HR (Prakash 
et al., 2015). Since a homologous sequence is used as a template to copy back the information 
missing at the DSBs site, this is the only way the cell can repair a DSB in an error-free way. 
Upon resection of the broken DNA ends, the recombinase RAD51 needs to be loaded on the 
ssDNA ends to mediate homologous pairing and strand invasion. However, RAD51 loading 
on ssDNA ends is inhibited by RPA and in mammals it is facilitated by the mediator protein 
BRCA2 (Prakash et al., 2015). BRCA2 binds RAD51 through two unrelated domains: the 
BRC repeats and the C-terminal domain. While each BRC repeat can bind one single RAD51 
monomer, the C-terminal domain (TR2), in its non-phosphorylated form, only binds the 
oligomeric RAD51. Upon DNA damage, BRCA2-TR2 binds RAD51 oligomers and 
mediates their assembly on ssDNA ends. Once damage has been repaired, BRCA2-TR2 gets 
phosphorylated and loses the ability to bind RAD51 oligomers. Consequently, RAD51 
oligomers that are not anymore protected by the interaction with BRCA2-TR2 are destroyed 
by the interaction with the BRC repeats that keep RAD51 in a monomeric form (Davies and 
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Pellegrini, 2007, Esashi et al., 2007). Additionally, BRCA2 interacts with BRCA1 through 
PALB2. Interestingly, this interaction is cell-cycle controlled and contributes to DNA repair 
pathway choice, as discussed in the next section (Orthwein et al., 2015). Once ssDNA-
RAD51 nucleoprotein filaments have been formed, homology search and strand invasion 
generates a D-loop which primes the DNA polymeras δ-mediated extension of the invading 
DNA. This results in the formation of different DNA intermediates, whose resolution 
completes the HR process and generates crossover or non-crossover products, the latter 
process also known as gene conversion (Jasin and Rothstein, 2013) (figure 2b).  
1.1.3.2.1 DNA end resection and its role in DSB repair pathway choice 
DNA end resection is the key step in DSB repair pathway choice. Once a DSBs has been 
resected it cannot be repaired anymore via NHEJ. Indeed, DNA end resection not only 
generates the ssDNA stretches that are essential for HDR, but it also inhibits Ku70/80 
binding (Tomimatsu et al., 2012, Shao et al., 2012). Cell-cycle phase strongly influences 
DSB pathway choice (Hustedt and Durocher, 2016), mainly by impacting on expression and 
activity of CtIP (Ferretti et al., 2013). CDK-dependent phosphorylation on Thr847 is crucial 
for CtIP recruitment to DSBs and resection initiation (Huertas and Jackson, 2009), while the 
CDK-dependent phosphorylation on Ser327 stimulates its binding to BRCA1 (Yu and Chen, 
2004), which is not essential for DNA end resection and only increases the rate of the process 
(Cruz-Garcia et al., 2014). CDK-mediated control of DNA end resection also relies on EXO1 
and NBS1 phosphorylation (Ferretti et al., 2013). The CDK-mediated phosphorylation of 
CtIP also adds a further layer of regulation by promoting the binding of the prolyl isomerase 
PIN1, which mediates a conformational change that targets CtIP to proteasomal degradation 
(Steger et al., 2013). In addition, CtIP activity is positively regulated by SIRTUIN 6 
(SIRT6)-mediated deacetylation (Kaidi et al., 2010) (figure 4b).  
Two key factors in regulating DNA end resection and, therefore, DSB repair pathway choice 
are BRCA1 and 53BP1. BRCA1 is a key protein in HR, and 53BP1 has been shown to 
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promote NHEJ of a subset of DSBs, such as at dysfunctional telomeres (Dimitrova et al., 
2008). Perturbation of the delicate balance between 53BP1 and BRCA1 at site of damage, 
resulting from cell-cycle phase (Hustedt and Durocher, 2016) or other factors such as 
chromatin status (Tang et al., 2013), channels the repair pathway toward either NHEJ or 
HDR, mainly by licensing or not DNA end resection. Upon DNA damage, ATM-mediated 
phosphorylation of 53BP1 promotes recruitment of the resection “blockers” PAX 
transactivation activation domain-interacting protein (PTIP) (Callen et al., 2013) and RAP1-
interacting factor 1 (RIF1) (Chapman et al., 2013, Zimmermann et al., 2013), thus inhibiting 
DNA end resection (figure 4a). In the absence of 53BP1, BRCA1 can still localize to DSBs 
in G1 phase cells, but it is not able to recruit the BRCA2-PALB2 complex required for HR 
(Orthwein et al., 2015). The interaction of BRCA1 with the PALB2-BRCA2 complex is 
indeed cell-cycle regulated through the ubiquitylation of the BRCA1-interacting domain of 
PALB2 (Orthwein et al., 2015). During the S/G2 phase of the cell cycle the barrier posed by 
53BP1 to DNA end resection is neutralized by BRCA1 (Escribano-Diaz et al., 2013). Indeed, 
the HR deficiency of BRCA1-depleted cells is recued in the absence of 53BP1 (Bunting et 
al., 2010). Moreover, super-resolution microscopy show a BRCA1-dependent change in the 
morphology of 53BP1 foci during the S/G2 phase (Chapman et al., 2012a), indicating that 
BRCA1 may facilitate DNA end resection by repositioning 53BP1 away from the DSB ends 
(figure 4b).  
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adapted from (Chapman et al., 2012b) 
Figure 4: DSB repair pathway choice  
(a) In G1 phase, ATM-mediated phosphorylation of 53BP1 allows the binding of the two resection “blockers” 
RIF1 and PTIP. 53BP1-bound RIF1 prevents the association of BRCA1 with CtIP, therefore inhibiting DNA 
end resection and favoring NHEJ. The mechanism of PTIP-mediated inhibition of DNA end resection is still 
not known. (b) During S phase, CDK-mediated phosphorylation of CtIP promotes its binding to BRCA1 and 
prevents 53BP1–RIF1, and possibly also 53BP1–PTIP, chromatin association. KAT5-mediated acetylation of 
H4K16 (H4K16ac) further reduces 53BP1 chromatin association. Additionally, CtIP activity is controlled by 
SIRT6, a deacetylase that removes an inhibitory acetylation mark on CtIP.  
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1.2 A novel role of RNA in DNA damage signaling and repair 
1.2.1 Transcription and DDR 
Transcription has been traditionally considered a dangerous process for genome stability 
(Aguilera and Gaillard, 2014). Collision of the transcription and replication machinery or 
DNA:RNA hybrids accumulation have been associated with genome instability. Moreover, 
transcription of damaged genes can lead to the generation of aberrant transcripts that can 
negatively affect cell viability. In order to avoid this risk, transcription of broken genes is 
silenced upon DNA damage (Iannelli et al., 2017, Pankotai et al., 2012, Shanbhag et al., 
2010). However, transcriptional silencing of damaged genes co-exists with de novo 
transcription of sncRNAs with a function in DNA damage signaling and repair (Rossiello et 
al., 2017, Francia et al., 2012, Wei et al., 2012, Michalik et al., 2012). Differently from 
sncRNAs generated at the site of damage, which contribute directly to DNA damage 
signaling and repair, other RNA species, including miRNA and lncRNA, have also been 
reported to regulate these processes, for example through modulation of DDR proteins level, 
thus pointing to an unambiguous role for RNA in DNA damage signaling and repair.    
1.2.1.1 DSB-induced transcriptional silencing  
Transcription of a damaged gene may result in the production of aberrant transcripts that 
could be dangerous for the cell. In order to avoid this problem, cells have evolved 
mechanisms to silence the expression of damaged genes. A DSB within the gene body leads 
to DNA-PK mediated exclusion of RNA polymerase II (RNA pol II) from the gene body 
and its promoter (Pankotai et al., 2012). In a different system, in which multiple DSBs are 
induced upstream of a reporter gene, transcriptional silencing relies on ATM-dependent 
chromatin condensation associated with RNF8- and RNF168-mediated ubiquitination of the 
histones H2A/H2AX (Shanbhag et al., 2010). Strengthening the link between ubiquitination 
and transcriptional repression, reduced de novo mRNA synthesis has been observed in 
ubiquitin-enriched chromatin domains resulting from spontaneous DNA lesions 
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(Gudjonsson et al., 2012). ATM-mediated gene silencing upon DSB induction in proximity 
to or within a gene has been further supported by a recent study that combines transcriptome 
profiling with γH2AX ChIP-seq with a new method for “breaks labelling in situ and 
sequencing” (BLISS) (Yan et al., 2017), which directly labels and amplifies DSBs ends in 
situ, thus allowing a high-resolution genome-wide mapping of DSBs (Iannelli et al., 2017). 
In summary, transcription does not seem to be inhibited by the lesion per se, but by the 
consequent DDR activation. ATM-dependent transcription inhibition also impacts on RNA 
Pol I transcription of rDNA (Kruhlak et al., 2007). Damage-induced transcriptional silencing 
has been observed also in yeast (Lee et al., 2000), where it is due to the resection of both the 
template and the non-template sequence (Manfrini et al., 2015).  
1.2.1.2 Transcription, DNA:RNA hybrids formation and genome instability  
It is known since a long time that transcription can induce DNA damage (Skourti-Stathaki 
and Proudfoot, 2014). DNA damage and recombination may arise upon replication-fork 
stalling resulting from the collision between the transcription and replication machineries 
(Branzei and Foiani, 2010, Helmrich et al., 2013). Moreover, pairing of the nascent RNA 
with the template DNA may generate DNA:RNA hybrids that displace the non-template 
ssDNA to generate three-stranded nucleic acid structures named R-loops (Reaban et al., 
1994). DNA:RNA hybrids form physiologically during DNA replication (Aguilera and 
Garcia-Muse, 2012) and participate in several physiological processes (Santos-Pereira and 
Aguilera, 2015), including immunoglobulin gene class-switch recombination (Yu et al., 
2003), transcription activation of CpG islands promoters (Ginno et al., 2012), and 
transcription termination (Skourti-Stathaki et al., 2011). However, several factors, such as 
G content (Roy and Lieber, 2009), negative supercoiling associated with transcription 
(Drolet, 2006) in the context of topoisomerases deficiency (Drolet et al., 1995, Tuduri et al., 
2009, El Hage et al., 2010), collision between transcription and replication machinery 
(Helmrich et al., 2011), and pausing of RNA pol II (Grabczyk et al., 2007, Lin et al., 2010, 
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Reddy et al., 2011), may be responsible for unscheduled R-loops formation and genome 
instability. On one hand, R-loops expose ssDNA to several assaults that undermine genome 
stability (Aguilera, 2002). On the other hand, the higher recombination rate observed at 
highly transcribed genes has been shown to rely on DNA replication (Gottipati et al., 2008), 
supporting the idea that R-loop-mediated genome instability may arise from replication fork 
stalling (Wellinger et al., 2006, Tuduri et al., 2009, Gan et al., 2011).  
In order to avoid the detrimental effects of DNA:RNA hybrids accumulation, the equilibrium 
between their formation and resolution must be tightly controlled. This is possible by either 
preventing DNA:RNA hybrids formation through coating of the nascent RNA with RNA 
binding proteins (RBPs), or by removing DNA:RNA hybrids already formed (Santos-Pereira 
and Aguilera, 2015). The key protein responsible for DNA:RNA hybrids resolution are 
RNase H enzymes (Cerritelli and Crouch, 2009, Wahba et al., 2011), and helicases like 
Aquarius (Sollier et al., 2014), Senataxin (Skourti-Stathaki et al., 2011, Mischo et al., 2011, 
Alzu et al., 2012), and Pif1 (Chib et al., 2016, Tran et al., 2017)   
1.2.1.2.1 Focus on RNase H enzymes 
RNase H are the enzymes responsible for the degradation of the RNA strand of DNA:RNA 
hybrids (Cerritelli and Crouch, 2009). In eukaryotes two classes of RNAse H exist: the 
monomeric RNAse H1 (type 1) and the heterotrimeric RNAse H2 (type 2). While RNAse 
H1 is only able to cleave DNA:RNA hybrids formed of at least four consecutive 
ribonucleotides embedded in a dsDNA sequence, RNAse H2 can hydrolyze the vast majority 
of DNA:RNA hybrids in the cell and provides the major RNAse H function in eukaryotes 
(Cerritelli and Crouch, 2009) (figure 4). However, extended DNA:RNA hybrids can be 
degraded by either RNase H1 and RNase H2 (Cerritelli and Crouch, 2009). Mammalian 
RNase H1 has a nuclear isoform with a still unclear function and a mitochondrial isoform 
with a key role in mitochondrial DNA replication (Cerritelli et al., 2003). RNase H2 is a 
heterotrimeric complex composed of a conserved catalytic subunit (RNase H2A) and 
auxiliary subunits (RNase H2B and RNase H2C) (Cerritelli and Crouch, 2009), which form 
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a soluble stable complex subsequently bound by the subunit A to form the final functional 
complex. Moreover, the auxiliary proteins can mediate the interaction with other proteins 
and support other un-known functions. For example, RNase H2B mediates the interaction 
with PCNA, linking RNase H2 to replication and repair (Chon et al., 2009). Mutations in 
any of the human RNase H2 subunits can result in Aicardi-Goutieres syndrome (AGS), an 
neuroinflammatory disease reminiscent of congenital viral infections, possibly caused by the 
chronic activation of the immune system by excessive accumulation of aberrant forms of 
nucleic acids (Crow et al., 2006).  
RNase H2 activity is crucial for genome stability. First, RNase H2 removes misincorporated 
ribonucleotides from genomic DNA (Sparks et al., 2012), whose accumulation can interfere 
with replication fork progression (Watt et al., 2011) and has been associated with DNA 
damage breakage and mutagenesis (Pizzi et al., 2015). Additionally, RNase H2 is 
responsible for the resolution of DNA:RNA generated by RNA polymerases during 
transcription (El Hage et al., 2010, Lin et al., 2010), whose accumulation would otherwise 
negatively impact on the transcription itself and genome stability. At yeast telomeres, RNase 
H2 regulates DNA:RNA hybrids levels (Graf et al., 2017). Short telomeres fail to accumulate 
RNase H2 and the consequent DNA:RNA hybrids accumulation is associated to DNA 
damage and HR (Graf et al., 2017).  
 
  adapted from (Cerritelli and Crouch, 2009) 
Figure 4: RNase H substrates and cleavage pattern  
RNase H1 and RNase H2 have different substrates and different cleavage patterns on the same substrate.   
Single ribonucleotides embedded in a duplex DNA are cleaved only by RNase H2, and not by RNase H1 (a) 
Four consecutive ribonucleotides in a duplex DNA (b) or RNA/DNA hybrids (c) are cleaved differently by 
RNase H1 and RNase H2 
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1.2.1.3 A novel link between HR proteins, RNA processing, and DNA:RNA hybrids   
As mentioned before, BRCA1 is a multifaceted protein with key roles not only in DNA 
damage signaling and repair, but also in several other cellular processes. For example, 
BRCA1 interacts with several transcription and RNA processing factors, including RNA pol 
II (Scully et al., 1997, Anderson et al., 1998). Upon damage, BRCA1 forms a complex with 
mRNA splicing factors to mediate the splicing and the stability of a subset of BRCA1 bound 
promoters, including promoters of genes controlling DNA repair and genome stability 
(Savage et al., 2014). Moreover, BRCA1 participates in miRNA biogenesis by recognizing 
miRNAs precursors and promoting their processing through interaction with DROSHA 
(Kawai and Amano, 2012).  Recently, a strong and controversial link between BRCA1, 
BRCA2, RAD51 and DNA:RNA hybrids has emerged. On one hand, the accumulation of 
DNA:RNA hybrids and the associated genome instability observed in yeast RNA processing 
mutants has been attributed to the recombination protein Rad51 (Wahba et al., 2013), 
introducing a new and unforeseen role for a protein known as a “warden” of  genome 
stability (Tan-Wong and Proudfoot, 2013). Stimulation of DNA:RNA hybrid formation had 
been also reported in the past for the bacterial Rad51 homologue RecA (Kasahara et al., 
2000, Zaitsev and Kowalczykowski, 2000). On the other hand, DNA:RNA hybrids 
accumulation has been observed in cells depleted for the HR proteins BRCA1 and BRCA2, 
but not RAD51 (Bhatia et al., 2014, Tan et al., 2017). In line with these results, BRCA1-
mediated recruitment of SENX suppresses genome instability induced by DNA:RNA 
hybrids accumulation at the termination region of the β-actin gene (Hatchi et al., 2015). The 
link between BRCA2 and DNA:RNA hybrids is less clear. The observation that DNA:RNA 
hybrids do not accumulate upon RAD51 depletion, together with the cell-cycle independent 
accumulation of DNA:RNA hybrids in BRCA2-depleted cells, suggests a possible 
uncoupling between BRCA2 function in DNA:RNA hybrids resolution and its well 
established role in HR (Bhatia et al., 2014). However, further supporting the connection 
between BRCA2 and DNA:RNA hybrids, some of the proteins that participate, together with 
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BRCA2, in the Fanconi Anemia (FA) repair pathway localize to DNA damage sites via 
DNA:RNA hybrids and suppress DNA:RNA hybrids associated genome instability (Garcia-
Rubio et al., 2015, Schwab et al., 2015). 
1.2.1.4 The positive impact of transcription on DSB repair 
A growing body of evidence supports a role for transcription in DNA damage repair. DSBs 
are repaired faster in actively transcribed genes compared to inactive genes (Chaurasia et al., 
2012) and preferentially via HR (Aymard et al., 2014). In human cells, endonuclease-
induced DSBs have been classified in HR- and NHEJ-repair prone, on the bases of the 
enrichment of RAD51 or XRCC4 proteins, respectively (Aymard et al., 2014). HR-prone 
DSBs are mainly located in transcriptionally active chromatin, which is enriched in 
H3K36me3 or H3K9Ac chromatin marks. Recognition of active chromatin by accessory 
proteins mediates the recruitment of key HR proteins, thus fueling HR (Aymard et al., 2014).  
1.2.2 RNA binding proteins and transcription factors recruitment to DNA lesions 
In the last years, factors involved in several aspects of RNA metabolism have been found in 
proteomic and functional DDR screens (Matsuoka et al., 2007, Paulsen et al., 2009, 
Bennetzen et al., 2010, Bensimon et al., 2010) or have been reported as ATM or ATR 
substrates (Matsuoka et al., 2007). Moreover, an increasing number of transcription factors 
and RBPs have been reported to localize to DNA damage sites (Izhar et al., 2015), where 
they may directly participate in DDR (Dutertre et al., 2014). For example, DNA end 
resection is stimulated by hnRNPUL1/2 (heterogeneous nuclear ribonucleoprotein U-like), 
RBPs that control several aspects of RNA maturation (Polo et al., 2012). In particular, 
hnRNPUL1/2 localize to DSBs in an MRN-dependent way and stimulate DNA end resection 
by recruiting the helicase BLM. This process can be further stimulated by PRP19, an E3 
ubiquitin ligase involved in pre-mRNA splicing, that interacts with and ubiquitylates RPA, 
favoring the accumulation ATR-ATRIP complex and further amplification of DDR 
signaling (Marechal et al., 2014). Additionally, components of the exosome, a complex 
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involved in RNA processing and degradation, have been shown to localize to DSBs, where 
they promote repair by HR (Marin-Vicente et al., 2015, Manfrini et al., 2015).   
1.2.3 The role of RNA in DDR 
Transcriptional modulation of DSB repair does not only rely on chromatin status but also on 
transcription products, either pre-existing or produced upon DNA damage, that can modulate 
both DDR signaling and repair (d'Adda di Fagagna, 2014). NHEJ proteins have been 
described to interact with nascent RNAs at DSBs located in actively transcribed genes 
(Chakraborty et al., 2016). In particular, following DSB induction, RNA pol II co-
immunoprecipitates with both the NHEJ proteins Lig IV, XRCC4, Ku-70, Pol µ, DNA-PK 
and the HR proteins RAD51 and RAD52 (Chakraborty et al., 2016), thus indicating a 
possible role of the RNA itself in facilitating the recruitment or activation of DDR factors. 
Moreover, sncRNAs with the sequence of the damaged DNA are generated upon DSB in 
several organisms (Rossiello et al., 2017, Francia et al., 2012, Wei et al., 2012, Michalik et 
al., 2012). Our laboratory recently discovered that these damage-induced sncRNAs are 
generated from DROSHA- and DICER-mediated processing of longer precursor RNAs, 
which are transcribed from the broken DNA ends (Michelini et al., in press). Although de 
novo transcription and transcriptional inhibition at DSBs may sound as two mutually 
exclusive events, they could also fit in a unique scenario. Upon DSB induction, chromatin 
undergoes a first relaxation phase to allow the access of DDR proteins to the site of damage, 
and then a condensation phase necessary for further amplification of DDR signaling (Price 
and D'Andrea, 2013). An intriguing hypothesis would be that relaxed and easily accessible 
chromatin could facilitate the recruitment of transcription factors at DNA damage site. 
Recruitment of transcription factors might enhance transcription by RNA pol II, whose 
recruitment could, in turn, be favored by the chromatin relaxation or be the result of a more 
regulated mechanism. RNA pol II-mediated transcription of small RNA transcripts would 
then favor DDR activation (Francia et al., 2012) that, in turn, would induce to DNA damage 
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induced transcriptional silencing.  
1.2.3.1 Biogenesis and function of damage-induced sncRNAs   
Recent data support the generation of small ncRNAs upon DSB in several organisms 
(Rossiello et al., 2017, Francia et al., 2012, Wei et al., 2012, Michalik et al., 2012). In 
Drosophila cells, transfection of a linearized plasmid generates sncRNAs when the 
linearization truncates a transcribed region (Michalik et al., 2012). The production of these 
small RNA, with the sequence of the linearized ends, induces the post-translational silencing 
of the truncated gene, in a process known as endo-siRNA response. This process can be 
assimilated to a well-known and evolutionary-conserved mechanism known as RNA 
interference (RNAi), in which small RNA molecules, like siRNA, cause gene silencing 
(Ghildiyal and Zamore, 2009). Cleavage of a double-stranded precursor by DICER generates 
siRNAs, that are loaded on Argonaute proteins in the RNA-Induced Silencing Complex 
(RISC) to repress the expression of target transcripts. microRNA (miRNA) are another class 
of sncRNAs with a function similar to siRNAs, but slightly different biogenesis. miRNA 
biogenesis requires the additional cleavage of an hairpin precursor RNA by DROSHA, thus 
generating the dsRNA substrate for subsequent DICER cleavage. miRNAs are then loaded 
in the RISC complex and inhibit mRNA translation in a process mediated by the GW-182 
family proteins. 
In mammalian cells, DSB induction is followed by the production of sncRNAs with the 
sequence of the damaged locus, known as DNA damage response RNAs (DDRNAs) 
(Francia et al., 2012). Importantly, DDRNAs are not generated by processing of transcripts 
already present at the site of damage, rather they are the result of de novo transcription from 
broken DNA ends. Our laboratory recently demonstrated that RNA pol II is recruited to 
DSBs where it synthesizes damage-induced long non-coding RNAs (dilncRNAs), from and 
towards the broken DNA ends. DilncRNAs are processed by DROSHA and DICER to 
generated DDRNAs and they also mediate DDRNAs recruitment to the DSBs via 
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RNA:RNA pairing (Michelini et al., in press). While in the canonical RNAi pathway, 
DROSHA and DICER process the precursor transcripts respectively in the nucleus and in 
the cytoplasm, the exact cellular sub-compartment in which DDRNAs processing takes place 
is not known yet but it is likely to be nuclear. Indeed, the exclusively cytoplasmic 
localization of DICER (Billy et al., 2001, Provost et al., 2002, Much et al., 2016) has been 
recently challenged by several lines of evidence in favor of a nuclear localization and 
function (Sinkkonen et al., 2010, Ando et al., 2011, Ohrt et al., 2012, Gullerova and 
Proudfoot, 2012, Doyle et al., 2013, Gagnon et al., 2014, Skourti-Stathaki et al., 2014, White 
et al., 2014, Matsui et al., 2015, Neve et al., 2016). More conclusively, the laboratory of 
Monika Gullerova has recently shown that DNA damage-dependent DICER 
phosphorylation is required for its nuclear localization. Once recruited to the site of damage, 
two additional phosphorylation events control dsRNA processing, thus contributing to the 
recruitment of DDR proteins (Burger et al., 2017). It is therefore highly likely that DDRNAs 
are fully processed at DNA damage sites, where they also mediate DDR activation and DDR 
foci formation (d'Adda di Fagagna, 2014) (figure 5, right). The observation of DDRNAs 
production upon damage has been recently extended to an endogenous physiological locus 
(Rossiello et al., 2017). Our group reported that uncapped/damaged telomeres produce both 
G-rich and C-rich telomeric dilncRNAs that are processed by DROSHA and DICER to 
produce short RNAs, named telomeric DDRNAs (tDDRNAs), that are necessary for full 
DDR activation. 
Similar RNA species, named diRNAs (DSB-induced RNAs) (Wei et al., 2012), bind AGO2 
and promote HR by mediating the loading of AGO2-bound RAD51 to ssDNA ends (Gao et 
al., 2014). Moreover, they interact with and mediate the proper localization of the two 
chromatin modifiers MMSET and TIP60, that in turn favor chromatin relaxation and the 
recruitment of the HR proteins BRCA1 and RAD51 (Wang and Goldstein, 2016) (figure 5, 
left).  
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 adapted from (D'Alessandro and d'Adda di Fagagna, 2016) 
Figure 5: sncRNAs in DNA damage signaling and repair 
Upon damage, small RNA species (diRNAs and DDRNAs) are generated by DROSHA- and DICER-mediated 
processing of a longer RNA transcribed by RNA pol II. DDRNAs contribute to DDR activation by promoting 
the “secondary recruitment” of DDR proteins, including pATM, MDC1, and 53BP1, to DSBs. “Primary 
recruitment” of DDR proteins, such as the MRN complex, and H2AX phosphorylation are DDRNAs-
independent (b). AGO2-bound diRNAs promote HR by either recruiting the AGO2–RAD51 complex to DNA 
lesions, or by recruiting the chromatin remodeler MMSET and TIP60, which induce a permissive chromatin 
status for BRCA1 and RAD51 loading and HR-mediated repair.   
 
1.2.3.2 DNA:RNA hybrids in DSB repair 
A growing body of evidence suggests that DNA:RNA hybrids form at nicks (Roy et al., 
2010) and DSBs (Ohle et al., 2016, Li et al., 2016, Li et al., 2008, Britton et al., 2014) and 
that they have a role in DNA repair. DNA:RNA hybrids formation upon damage is supported 
by the observation of transcription-dependent accumulation of the catalytically inactive 
Escherichia coli RNase H at laser micro-irradiation sites in human cells (Britton et al., 2014). 
Moreover, the human RNA-unwinding protein DEAD box 1 (DDX1) has been shown to 
localize to IR-induced DSBs. Damage induced localization of DDX1 at DSBs is depended 
on transcription and DNA end resection and it is abrogated by treatment with recombinant 
RNase H (Li et al., 2008, Li et al., 2016). Moreover, DNA:RNA hybrids accumulation upon 
DDX1 depletion impairs HR-mediated repair (Li et al., 2016). In Schizosaccharomyces 
pombe, RNA pol II localization and DNA:RNA hybrids formation at DSBs has been 
observed (Ohle et al., 2016). In particular, DNA:RNA hybrids formation is facilitated by 
DNA end resection and modulates HR by impacting on RPA loading on ssDNA stretches. 
MRE11
NBS1
RAD50
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HR is only proficient in the presence of RNase H activities. Interestingly, either lack of both 
RNase H1 and RNase H2 or RNase H overexpression hampers DSB repair capacity. In 
particular, while RNase H depletion is associated with reduced RPA loading on ssDNA ends, 
upon RNase H overexpression RPA loading spreads further away from the DSBs, indicating 
an over-resection possibly causing the choice of other DNA repair pathways, such as SSA, 
rather than HR. Therefore, only a certain level of DNA:RNA hybrids favors DSB repair: an 
excessive level impedes RPA loading, while an insufficient level allows over-resection and 
the choice of pathways alternative to HR. At telomeres, DNA:RNA hybrids positively 
modulate HR-mediated repair (Graf et al., 2017, Balk et al., 2013, Arora et al., 2014, Pfeiffer 
et al., 2013, Yu et al., 2014). In yeast and mammalian telomerase negative cells, elongation 
of damaged telomeres is controlled by DNA:RNA hybrids formed upon hybridization of 
long noncoding telomeric repeat-containing RNA (TERRA) with the template DNA (Graf 
et al., 2017, Balk et al., 2013, Arora et al., 2014, Pfeiffer et al., 2013, Yu et al., 2014). In 
particular, TERRA and the associated DNA:RNA hybrids levels increase at the G1/S 
transition, before being degraded during progression from the S to the G2 phase (Graf et al., 
2017). Recent data show that RNase H2, which is the major source of DNA:RNA hybrid 
nucleolytic activity in eukaryotic cells (Cerritelli and Crouch, 2009), is recruited to telomeres 
where it mediates DNA:RNA hybrids degradation. However, when telomeres become 
critically short, RNase H2 does not localize anymore to shortened telomeres and DNA:RNA 
hybrids accumulate. This leads to HR possibly due to collision between DNA:RNA hybrids 
and the replication machinery.  
DNA:RNA hybrids are also intermediates of a newly discovered repair pathway known as 
RNA-templated repair. While it was already known that exogenous RNA oligonucleotides 
could template DSBs repair in yeast and human cells (Storici et al., 2007, Shen et al., 2011), 
only recently a role for endogenous RNA molecules in templating HR-mediated DSBs has 
been demonstrated (Keskin et al., 2014). Endogenous transcripts can either template the 
synthesis of cDNA molecules or be directly used as templates for HR, by forming 
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DNA:RNA hybrids intermediates. Key player in the RNA-templated DNA is the HR protein 
Rad52 (Keskin et al., 2014, Mazina et al., 2017) , that has been shown to catalyze in vitro 
the annealing of RNA to DNA (Keskin et al., 2014), mediating the formation of DNA:RNA 
hybrids. More recently, it has been also shown that yeast and human RAD52 catalyze in 
vitro an inverse strand-exchange reaction with DNA or RNA (Mazina et al., 2017). In the 
same setting no RAD51 mediated stimulation of RNA inverse strand exchange has been 
observed, although DNA:RNA hybrids formation has been also associated with Rad51 in 
yeast (Wahba et al., 2013) and RecA, the bacterial Rad51 orthologue, has been reported to 
promote paring between duplex DNA and ssRNA in vitro (Zaitsev and Kowalczykowski, 
2000). Interestingly, inverse RNA strand exchange is stimulated by RPA, possibly via 
protein-protein interaction with RAD52, but it is still efficiently mediated by the Rad52 N-
terminal domain (NTD), which lacks the RAD51 and RPA binding domains, pointing out to 
a unique role for Rad52 in this process (Mazina et al., 2017). The formation of DNA:RNA 
hybrids during this process is further supported by the observed stimulation of RNA-
templated repair in the absence of RNase H functions (Keskin et al., 2014).  
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2 Materials and Methods 
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2.1 Cell culture  
All the cell lines used were grown under standard tissue culture conditions (37°C, 5% CO2). 
HeLa and U2OS cells were used to study DDR foci formation and were grown respectively 
in MEM supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, 1% 
penicillin/streptomycin, and McCoy supplemented with 10% FBS, 1% L-glutamine, and 1% 
penicillin/streptomycin. HeLa-FUCCI (RIKEN BioResource Center cell bank) (Sakaue-
Sawano et al., 2008) were used to perform cell cycle studies and were grown in DMEM 
supplemented with 10% FBS, 1% L-glutamine, and 1% penicillin/streptomycin. 
Dox-inducible I-SceI/DR-GFP (TRI-DR-U2OS) (kind gift from P. Oberdoerffer) are U2OS 
cells containing the DR-GFP reporter system and a doxyciclin-inducible I-SceI expressing 
vector. When I-SceI expression is induced (by adding 5 µg/ml doxycycline to the cell 
medium) I-SceI target sequence is cut and a recombination event between two mutated GFP 
cassettes generates the correct GFP sequence which is translated into a functional GFP that 
confers the green color to the cells. TRI-DR-U2OS cells were grown in DMEM 
supplemented with 10% FBS, 1% L-glutamine, and 1% penicillin/streptomycin.  
DIvA cells (AsiSI-ER-U20S) (kind gift from G. Legube) were cultured in DMEM without 
phenol red supplemented with 10% FBS, 1% L-Glutamine, 1% pyruvate, 2.5% HEPES, 1% 
penicillin/streptomycin, and 1 µg/ml puromycin as a selection marker. AsiSI-dependent 
DSBs induction was obtained by treating the cells with 300 nM 4OHT (Sigma-Aldrich) for 
4 hours. 
U2OS19ptight (kind gift from E. Soutoglou) were grown in DMEM without phenol red 
supplemented with 10% FBS Tetracycline tested, 1% L-glutamine and G418 (800µg/mL). 
I-SceI expression was induced by adding 1µg/mL doxycycline for 16 hours. 
U2OS D210N-GFP were provided by our collaborator Pavel Jansack. These are U2OS cells 
in which the expression of an shRNA against the endogenous RNase H1 and the 
overexpression of a catalytically inactive RNase H1 mutant (D210N) is induced by adding 
doxycycline (1 µg/ml) to the cell media. U2OS D210N-GFP were grown grown in DMEM 
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without phenol red supplemented with 10% FBS Tetracycline tested, 1% L-glutamine, and 
1% penicillin/streptomycin. In general, medium without Phenol Red was used to avoid 
leakiness in the expression of the plasmids constitutively expressed or transfected in cells 
(i.e. upon I-PpoI transfection).  
U2OS cell synchronization for super-resolution imaging experiments was obtained by serum 
starvation. Briefly, cells were plated on glass coverslips for 24 hours. G0/G1 phase 
synchronization was achieved by replacing complete medium with serum free medium for 
72 hours. A mid-S phase cell population was obtained after 16 hours release into complete 
medium. Double strand breaks (DSBs) were generated by using the radiomimetic drug 
Neocarzinostatin (NCS) (Sigma-Aldrich).  
2.2 Ionizing radiation (IR) 
Ionizing radiation (IR) is a radiation able to ionize the target. The Gray (Gy) is the 
International System of Units of absorbed radiation dose, where 1 Gy is the absorption of 1 
joule of radiation energy by 1 kilogram of matter. When DNA is targeted by IR DSBs and 
several other types of DNA damage are generated. Here, DSBs were generated by using X-
rays, an electromagnetic type of IR, generated by a high-voltage X-rays generator tube 
(Faxitron X-Ray Corporation). 
2.3 Plasmid transfection 
For immunoprecipitation experiments, HEK293T cell were transfected with the calcium 
phosphate transfection method, that is based on the formation of calcium phosphate-DNA 
precipitates that bind the cell surface and enter the cell by endocytosis. Precipitates are 
obtained by slowly mixing a solution containing calcium chloride and DNA with a HEPES-
buffered saline solution containing sodium phosphate. In details, for a 10 cm dish, 10 µg of 
DNA was resuspended in 439µl of H2O with 61µl of CaCl2 (2M) and subsequently this 
solution was added to 500 µl of 2xHBS, constantly mixing. The mixture was added to the 
cells after 10 minutes incubation at RT. 
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For all the other experiments, plasmid transfection was performed by lipofection, a technique 
based on the formation of complexes between cationic synthetic lipids and negatively 
charged nucleic acids, that are then internalized in the cell. In particular, 90% confluent cells 
were transfected with Lipofectamine 2000 transfection reagent (Life Technologies). For 
each transfection reaction (in one well of a 6-well), 250 µl of serum-free medium (Opti-
MEM) were mixed with plasmidic DNA (usually 1 µg final concentration) and 250 µl of 
Opti-MEM were mixed with 6 µl Lipofectamine 2000 transfection reagent. The two 
solutions were incubated 5 minutes at RT, then mixed and incubated for 20 minutes at RT 
to allow the formation of lipid complexes. The mix was added to the cells for 6 hours and 
then fresh culture medium was added.  
Where indicated, 2 µg of mammalian RNase H1 expressing plasmid or HB-GFP (kind gift 
from A. Aguilera) or GFP-RNaseH1 (kind gift from N. Proudfoot) and their related control 
were transfected and experiments were performed 24 h after transfection. Where indicated, 
1 µg of Cherry-LacR (kind gift from E. Soutoglou) and 1 µg of RNase H2A (kind gift from 
M. Lee-Kirsch) were used. I-PpoI expression was obtained by transfection of 1 µg of 
mammalian ER-I-PpoI expressing plasmid (kind gift from M. Kastan). 24 h after 
transfection, nuclear translocation of ER-I-PpoI was induced by adding 4-OHT (Sigma-
Aldrich) at 2 µM final concentration for the indicated time.  
2.4 RNA interference 
Gene silencing was obtained by RNA interference, using short interfering RNAs (siRNAs). 
siRNA transfection was usually performed in 6-wells dishes on 30-50% confluent cells; for 
bigger plates volumes were scaled-up. For each transfection reaction 250 µl of serum-free 
medium (Opti-MEM) were mixed with siRNA oligo (5 to 20nM final concentration) and 
250 µl of Opti-MEM were mixed with 4 µl Lipofectamine RNAiMAX transfection reagent 
(Life Technologies). Lipid complexes formation was obtained by mixing and incubating the 
two solutions for 20 minutes at RT. The 500 µl mix was added to 1.5 ml of cell media and 
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72 hours later knockdown efficiency was tested and cells were used for further analysis. 
Sequences of the siRNA used are listed in table 1. 
 
 
 
 
   
Table 1: siRNA list 
Name Sequence 
LUCIFERASE GCCAUUCUAUCCUCUAGAGGAUG 
GFP AACACUUGUCACUACUUUCUC 
BRCA2  
1 GAAACGGACUUGCUAUUUA 
2 GGUAUCAGAUGCUUCAUUA 
3 GAAGAAUGCAGGUUUAAUA 
4 UAAGGAACGUCAAGAGAUA 
CtIP  
1  GGAGCUACCUCUAGUAUCA 
2 GAGGUUAUAUUAAGGAAGA 
3 GAACAGAAUAGGACUGAGU 
4 GCACGUUGCCCAAAGAUUC 
RAD51  
1 UAUCAUCGCCCAUGCAUCA 
2 CUAAUCAGGUGGUAGCUCA 
3 GCAGUGAUGUCCUGGAUAA 
4 CCAACGAUGUGAAGAAAUU 
RNase H1  
1 GACAGUAUGUUUACGAUAA 
2 GAGCACAGGUGGACCGGUU 
3 ACAAGAAUCGGAGGCGAAA 
4 GAGCAGGAAUCGGCGUUUA 
RNase H2  
1 CGGGAAAGGCUGUUUGCGA 
2 AAAUGGAGGACACGGACUU 
3 AUGCAUUGGACCAGGGCGU 
4 AGACCCUAUUGGAGAGCGA 
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2.5 LNA transfection  
Locked Nucleic Acid (LNA) are nucleic acids analogues in which a bridge between the 2' 
oxygen and 4' carbon “locks” the ribose in an ideal conformation for Watson-Crick binding.  
This peculiarity makes LNA highly thermally stable and increases their binding affinity for 
a complementary sequence. For this reason, LNAs are used as Antisense Oligonucleotides 
(ASOs) that bind the target nucleic acids and inhibit their further processing and/or function. 
DR-GFP cells were transfected with 20 nM LNA oligos following the procedure already 
described for siRNA (see “RNA interference” section). Before transfection, LNA solution 
was incubated at 95°C for 5 minutes and chilled on ice for 5 minutes, to prevent the 
formation of secondary structures of the oligos. Concomitantly with LNA transfection, I-
SceI expression was induced by adding doxycycline to the cell media. 72 h after the HR 
events were evaluated by amplification of the recombination products by PCR on genomic 
DNA (see section “DR-GFP reporter assay”) and by monitoring the percentage of GFP 
positive cells by FACS analysis (see section “Fluorescence-activated cell sorting”). LNA 
sequences are listed in table 2. 
2.6 Inhibition of RNA polymerase II transcription 
In order to specifically inhibit RNA polymerase II (RNA pol II) transcription, HeLa and 
U2OS cells were treated with α-amanitin (50 µg/mL) or 5,6-dichloro-1-β-D-
ribofuranosylbenzimidazole (DRB, 50 µM), respectively dissolved in deionized water and 
DMSO. α-amanitin is a toxin extracted from the mushroom Amanita phalloides that binds 
to RNA pol II, blocks RNA synthesis, and triggers RNA pol II degradation (Bushnell et al., 
2002, Nguyen et al., 1996). DRB inhibits RNA pol II elongation by targeting CDK9 and 
inhibiting CDK9-mediated phosphorylation of RNA pol II C-terminal domain (CTD) during 
transcription.   
Once the drugs were added, cells were irradiated and then fixed 6 hours later. For α-amanitin 
treatment, before adding the drug to the medium, cells were mildly permeabilized with 2% 
(HeLa cells) or 0.2% (U2OS cells) Tween 20 in PBS for 10 min at room temperature. RT-
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qPCR analysis of the the levels of c-fos RNA, a short-lived RNA specifically transcribed by 
RNA pol II, was used to monitor the efficacy and specificity of the drugs. 
Name Sequence 
CTRL AGAGAAAAGTGAAAGTCGAGT 
A1 TCGGGGTAGCGGCTGAAGCA 
A2 CGCCGTAGGTCAGGGTGGTC 
A3 GCCAGGGCACGGGCAGCTTG 
A4 CCGGTGGTGCAGATGAACTT 
A5 TCAGCTTGCCGTAGGTATTA 
B1 GGATCCACCGGTCGCCAC 
B2 AGCAAGGGCGAGGAGCTGTT 
B3 ACCGGGGTGGTGCCCA 
B4 GAGCTGGACGGCGACGTAAA 
B5 TTCAGCGTGTCCGGCTAGGG 
RA 1  TAATACCTACGGCAAGCTGA 
RA 2 CTGAAGTTCATCTGCACCAC 
RA 3 CAAGCTGCCCGTGCCCT 
RA 4 TCGTGACCACCCTGACCTA 
RA 5 TGCTTCAGCCGCTACCCCGA 
RB 1 GGATCCACCGGTCGCCAC 
RB 2 AGCAAGGGCGAGGAGCTGTT 
RB 3 ACCGGGGTGGTGCCCA 
RB 4 GAGCTGGACGGCGACGTAAA 
RB 5 TTCAGCGTGTCCGGCTAGGG 
                          Table 2: ASOs sequence   
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2.7 RNase A and RNase H treatment  
U2OS cells were plated on coverslips and irradiated (2Gy). 1 hour later cells were 
permeabilized with 0.2% Tween 20 in PBS for 10 minutes at RT. After 2 washes in PBS, 
each coverslip was incubated for 30 minutes at RT with 0.1 mg RNase A (USB corporation) 
or 15 U RNase H (USB corporation) diluted in 200 µl PBS with 5 mM MgCl2. Next, 
coverslips were washed twice in PBS and fixed and stained as described in the 
“immunofluorescence” section.  
2.8 RNA extraction and retro-transcription 
Total RNA from cultured cells was extracted with Maxwell® RSC simplyRNA Tissue Kit 
with the Maxwell® RSC Instrument (Promega), according to manufacturer instructions. 1 
µg of RNA was retro-transcribed using SuperScript VILO cDNA Synthesis Kit (Life 
Technologies), according to manufacturer instructions, and used as template in qRT-PCR 
analysis.  
2.9 Quantitative PCR (qPCR) 
A SYBR-green based system was used to perform qPCR. SYBR-Green is a fluorescent dye 
that binds the double-stranded DNA species produced during the PCR reaction, generating 
a fluorescent signal that is detected in real time by the real time qPCR machine.  
The low fluorescence detected during the initial PCR cycles defines the baseline 
fluorescence, above which a fixed fluorescence threshold is set. The cycle number at which 
the fluorescence is higher than the fixed threshold is the threshold cycle (Ct). 
For knock-down experiments, usually 10 ng of cDNA was used for RT-qPCR. The relative 
change in the level of the target molecule was calculated using the comparative CT method 
(i.e. 2ΔΔCT method) (Livak, 2001). This method is based on the calculation of ΔCt between 
the target gene and reference (housekeeping) in the sample analysed (ΔCtsample) and the 
control sample (ΔCtcontrol). 2ΔΔCt (with ΔΔCt = ΔCtsample-ΔCtcontrol) is the value indicating the 
level of expression of the target gene.  
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In case of ChIP and DRIP experiments, same volumes of immunoprecipitated chromatin 
were used for RT-qPCR analysis of different loci (see table 3 for primers). ChIP and DRIP 
data were normalized on the input.  
SYBR-Green based RT-qPCR experiments were performed on a Roche LightCycler 480 
machine using Roche SYBR and the following program: 
1. Denaturation: 95°C 15 min, 1 cycle 
2. Denaturation/Annealing/Extension: 95°C 15 sec > 60°C 20 sec > 72°C 30 sec, 50 cycles 
3. Melting curve: 40°C > 90°C > 40°C, 1 cycle 
 
NAME SEQUENCE 
qRT-PCR 
BRCA1_Fw 5’-ATCATTCACCCTTGGCACA-3’  
BRCA1_Rev 5’-ATGGAAGCCATTGTCCTCT-3’ 
BRCA2_Fw (start) 5’-AGCTTACTCCGGCCAAAAA-3’ 
BRCA2_Rev (start) 5’-TTCCTCCAATGCTTGGTAAATAA-3’ 
BRCA2_Fw (middle) 5’-CCTGATGCCTGTACACCTCTT-3’ 
BRCA2_Rev (middle) 5’-GCAGGCCGAGTACTGTTAGC-3’ 
BRCA2_Fw (end) 5’-TCCAAATCAGGCCTTCTTACTT-3’ 
BRCA2_Rev (end) 5’-GCTTGTTTTCTGCTTCATTGC-3’ 
c-FOS_Fw 5’-ACTACCACTCACCCGCAGAC-3’ 
c-FOS_Rev 5’-CCAGGTCCGTGCAGAAGT-3’ 
CtIP_Fw 5’-GGAAGAAAATAAAAAGCTTTCTGAAC-3’ 
CtIP_Rev 5’-TGCTTGATGCTGTTGATCATT-3’ 
RAD51_Fw 5’-TGAGGGTACCTTTAGGCCAGA-3’ 
RAD51_Rev 5’-CACTGCCAGAGAGACCATACC-3’ 
RNase H2A_Fw 5’-GAGAAAGAGGCGGAAGATGTTA-3’ 
RNase H2A_Rev 5’-TCTTCCTGAGTCCCTCCTGA-3’ 
RPP0_Fw 5’-TTCATTGTGGGAGCAGAC-3’ 
RPP0_Rev 5’-CAGCAGTTTCTCCAGAGC-3’ 
ChIP qPCR   
Rev 5’-ATCACATGGTCCTGCTGGAGTT-3’ 
Fw 5’-TGGCTGATTATGATCTAGAGTCGCGG-3’ 
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DRIP-qPCR 
DAB1_Right_1000_Fw 5’-TGGCCTCTAATGAGATGGAATCCC-3’ 
DAB1_Right_1000_Rev 5’-TTGGAGTCTAACAGCCCAGTCA-3’ 
DAB1_Right_1500_Fw 5’-GGTGATACTCACCACTATGCCT-3’ 
DAB1_Right_1500_Rev 5’-TCTGGGATGGGTGTTGAAGTGT-3’ 
DAB1_Right_2000_Fw 5’-TGC CTGTTTGCTTGATTTCCAC-3’ 
DAB1_Right_2000_Rev 5’-TGAGCTGGGGTCATGTTCTTGAG-3’ 
DAB1_Right_3000_Fw 5’-ATGCTGGTCCCATATAATCAGGC-3’ 
DAB1_Right_3000_Rev 5’-CTTCTGGGATTGTCTTGCTGGAGT-3’ 
DAB1_Right_3800_Fw 5’-GGCATTGTTCTGGGGATAAA-3’ 
DAB1_Right_3800_Rev 5’-TTGCCCAGGAGGTGACTC-3’ 
DAB1_Left_100_Fw 5’-TGTGCTCTTTCCACTGTGGT-3’ 
DAB1_Left_100_Rev 5’-ATCACACTCTGCCACGTATG-3’ 
DAB1_Left_1000_Fw 5’-GCAGCCACAATGGACTAAGA-3’ 
DAB1_Left_1000_Rev 5’-AGCCTTCAGTTCTGTTTCAC-3’ 
DAB1_Left_1500_Fw 5’-TTGCTCAGCTCTGCCCTCAAC-3’ 
DAB1_Left_1500_Rev 5’-AGTCAAGGCTAGGTGATTCC-3’ 
DAB1_Left_2000_Fw 5’-CCAACTTCTGTGCCTAGAAC-3’ 
DAB1_Left_2000_Rev 5’-GACTCCAGTGTGGCTAATC-3’ 
DAB1_Left_3000_Fw 5’-GCAGCCTAATTACTCATAGGG-3’ 
DAB1_Left_3000_Rev 5’-GCCTCCAAATTCTAGATCTC-3’ 
DAB1_Intergenic_Fw 5’-GATTCCACCAACCCCATTC-3’ 
DAB1_Intergenic_Rev 5’-GAGATTCCCACTGTCCCTAC-3’ 
AsiSI_Intergenic_Fw 5’-GCTGGAAGCTTCTGGAATCGTA-3’ 
AsiSI_Intergenic_Rev 5’-TTGTCAGTGCCCACCCTATGTT-3’ 
PCR 
ACTIN_Fw 5’-GATCATTGCTCCTCCTGAGC-3’ 
ACTIN_Rev 5’-AAAGCCATGCCAATCTCATC-3’ 
P1 5’-GAGGGCGAGGGCGATGCC-3’ 
P2 5’-TGCACGCTGCCGTCCTCG-3’ 
F1 5’-TTTGGCAAAGAATTCAGATCC-3’ 
F2 5’-CAAATGTGGTATGGCTGATTATG-3’ 
Table 3: primer list 
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2.10 Immunofluorescence and imaging analysis 
Immunofluorescence technique was mainly used to study DDR foci formation. Cells grown 
on coverslips were washed twice for 5 minutes with PBS and fixed with 4% PFA for 10 
minutes at RT. Then, cells were permeabilized with 0.2% Triton X-100 for 10 minutes at 
RT. In order to reduce the aspecific binding of the antibodies, 1 hour blocking in PBG (0.5% 
BSA, 0.2% gelatin from cold water fish skin in PBS 1X) was performed. After blocking, 
cells were stained with primary antibodies diluted in PBG for 1 hour at RT in a humidified 
chamber (primary antibodies used are listed in table 4). Next, cells were washed 3 times for 
5 minutes with PBG and incubated with secondary antibodies conjugated with different sets 
of fluorophores diluted in PBG for 45 minutes at RT in a dark humidified chamber. 
Secondary antibodies used were: goat anti-rabbit or anti-mouse Alexa 405 IgG (Life 
Technologies, 1:100, excitation wavelength 401 nm, emission wavelength 421 nm); donkey 
anti-mouse or anti-rabbit Alexa 488 IgG (Life Technologies, 1:100, excitation wavelength 
495 nm, emission wavelength 519 nm); donkey anti-mouse or anti-rabbit Cy3 IgG (Jackson 
Immuno Research, 1:400, excitation wavelength 550 nm, emission wavelength 570 nm), 
donkey anti-mouse or anti-rabbit Alexa 647 IgG (Life Technologies, 1:100, excitation 
wavelength 650 nm, emission wavelength 665 nm). After incubation with secondary 
antibodies, cells were washed twice for 5 minutes with PBG, twice for 5 minutes with PBS 
and incubated with 4'-6-Diamidino-2-phenylindole (DAPI, 1 µg/ml, Sigma-Aldrich, 
excitation wavelength 358 nm, emission wavelength 461 nm) for 2 minutes at RT. After 
DAPI staining, cells were washed once in PBS and once in water and coverslips were then 
mounted with mowiol mounting medium (Calbiochem), which is a polyvinyl alcohol 
solution containing an "anti-fade" agent, capable of reducing light-induced fading 
(photobleaching) of the fluorophore. Coverslips were air dried before microscope 
analysis.When ssDNA was visualized by BrdU native staining, cells were incubated with 
BrdU (Sigma-Aldrich, 10 µg/ml) for 24 h, in order to allow almost all the cells to incorporate 
the nucleotide analogue, and stained as described above.  
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For DNA:RNA hybrids detection, cells were fixed in ice-cold methanol for 10 minutes and 
then blocked and incubated with the S9.6 antibody (kind gift from M. Foiani) as described 
above.  
Immunofluorescence images were acquired using a widefield Olympus Biosystems 
Microscope BX71 and the MetaMorph software (Soft Imaging System GmbH). Confocal 
sections were obtained with a Leica TCS SP2 or AOBS confocal laser microscope by 
sequential scanning. Comparative immunofluorescence analyses were performed in parallel 
with identical acquisition parameters. Images were analysed software CellProfiler 2.1.1. 
(Carpenter et al., 2006). 
2.11 Super-Resolution (SR) imaging  
SR experiments were performed on U2OS cells seeded on coverslips and synchronized as 
described in the section “Cell culture”. Upon DNA damage induction, cells were pre-
extracted at RT for 3 minutes in CSK buffer (10 mM Hepes, 300 mM Sucrose, 100 mM 
NaCl, 3 mM MgCl2, and 0.5% Triton X-100, pH = 7.4) and fixed for 15 minutes in 
paraformaldehyde (3.7% from 32% EM grade, Electron Microscopy Sciences, 15714) and 
glutaraldehyde (0.3% from 70% EM grade, Sigma-Aldrich, G7776) in PBS. Blocking was 
performed in blocking buffer (2% glycine, 2% BSA, 0.2% gelatin, and 50 mM NH4Cl in 
PBS) for 1 hour at RT. Primary and secondary antibodies used are listed in table 4. 
Immediately before imaging analysis, coverslips were mounted onto a microscope 
microfluidics chamber and freshly prepared SR imaging buffer, comprising an oxygen 
scavenging system (1 mg/mL glucose oxidase (SigmaAldrich, G2133), 0.02 mg/mL catalase 
(SigmaAldrich, C3155), and 10% glucose (SigmaAldrich, G8270) and 100 mM 
mercaptoethylamine (Fisher Scientific, BP2664100) in PBS, was added to the imaging 
chamber. Images were acquired with a custom-built SR microscope based on a Leica DMI 
3000 inverted microscope. For each field 2000 sequential frames of single molecule 
emissions at 40 Hz were collected and imaged on a Prime 75B CMOS camera (Photometrics) 
using MicroManager. Each raw image stack was processed for single molecule localization 
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and rendered using 20 nm pixels via rapidSTORM. Monte Carlo simulations were used to 
randomly rearrange the clusters within an ROI to calculate a baseline level of random 
colocalization. Using this approach, 20 random simulations were generated for each nucleus 
in a pair-wise fashion, examining Red/Green, Red/Blue, and Green/Blue overlap. The total 
number of overlaps detected in each nucleus (typically 15-100) was normalized to the 
determined random level of overlap by dividing the number of real overlaps by the average 
number of overlaps in the same randomly-simulated nucleus. For display purposes, images 
were smoothed by applying a Gaussian blur filter and colors were thresholded to best 
produce a clear picture of the single foci.  
2.12 Proximity Ligation Assay (PLA)  
Proximity Ligation Assay (PLA) is a technique that can be used to assess the proximity 
(<40nm) of two candidate proteins by using DNA oligonucleotide conjugated-antibodies 
(PLA probes). Briefly, once epitopes have been recognized by primary antibodies raised in 
different species, DNA oligonucleotide-conjugated secondary antibodies are added. 
Ligation of the antibodies-conjugated oligos with connector oligonucleotides allows the 
formation of a close DNA circle.  In the following amplification step, one of the two oligos 
is used as primer for a rolling circle amplification (RCA). Fluorescent-tagged 
oligonucleotides complementary to the amplified DNA allow the visualization of the signal 
with a fluorescence microscope. Duolink in Situ FarRed Starter Kit Mouse/Rabbit (Sigma-
Aldrich) was used according to the manufacturer’s instructions. 
Briefly, cells were fixed in 4%, permeabilized in 0.2% Triton-X 100, and blocked in PBG1X, 
as described in the section “immunofluoresce and imaging analysis”. Incubation with 
primary antibodies was performed overnight at 4°C. After washing the primary antibodies 
(3 times in PBG1X), cells were incubated with PLA probes for 1 h at 37°C in a humid 
chamber. Cells were washed twice in Buffer A (supplied with the kit) and the ligation 
reaction was carried out at 37°C for 30 min in a darkened humidified chamber. After washing 
with Buffer A, cells were incubated with the amplification mix for 1.5 hours at 37°C in a 
	50	
darkened humidified chamber. After washing with Buffer B (supplied with the kit), cells 
were incubated with DAPI 0.2 µg/mL (Sigma-Aldrich) and mounted. Images were acquired 
using a widefield epifluorescent microscope (Olympus IX71) equipped with 40X objective. 
Quantification of nuclear PLA dots was performed with the automated image-analysis 
software CellProfiler 2.1.1. (Carpenter et al., 2006). 
Antibody Company and product ID Host  Applications 
IF PLA WB ChiP  
BRCA1 Santa Cruz, D-9 Mouse 1:400   2 µg/IP 
BRCA2 Calbiochem, OP-95 Mouse 1:400  1:1000  
BrdU GE Healthcare, RPN202 Mouse 1:800    
CENP-F Abcam, ab-5 Rabbit 1:400    
Cyclin A Santa Cruz, sc-751 Rabbit 1:200  1:1000  
Cyclin A BD transduction 
laboratories, 611268 
Mouse 1:400    
CtIP Bethyl, A300-488A Rabbit   1:6000  
PALB2 Gift of Xia Bing Rabbit     
RAD51 Abcam, Ab213 Mouse 1:200    
RAD51 Santa Cruz, sc-8349 Rabbit    1 µg/IP 
RAP80 Novus biological,NBP1-
87156 
Rabbit   1:6000  
RPA Calbiochem, NA18  Mouse 1:1000  1:1000  
RPA P-S4/8 Bethyl, A300-245A Rabbit 1:2000  1:2000  
RNase H1  Novus biological, NBP2-
20171 
Rabbit   1:1000  
RNase H2A 
(ab-1) 
Abcam, ab83943 Rabbit 1:1000 1:1000 1:1000  
RNase H2A 
(ab-2) 
Proteintech, 16132-1-AP Rabbit 1:1000 1:1000 1:1000  
RNase H2B Proteintech Rabbit 1:1000 1:1000 1:1000  
RNase H2C Proteintech Rabbit 1:1000 1:1000 1:1000  
S9.6 From M. Foiani’s lab  Mouse 1:500    
Tubulin Sigma-aldrich T5168 Mouse   1:5000  
Vinculin Sigma-aldrich V9131 Mouse   1:5000  
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γH2AX Millipore 05-636 Mouse 1:1000 1:1000   
γH2AX Abcam, ab2893  Rabbit 1:1000    
Table 4: Antibodies list 
2.13 DR-GFP reporter assay  
TRI-DR-U2OS cells were used to study homologous recombination. I-SceI expression was 
induced by adding 5 µg/ml Doxycycline. 72 h after induction, the HR efficiency was 
determined by quantifying GFP-positive cells (product of successful HR) by flow cytometry, 
as described in the section “Fluorescence-activated cell sorting (FACS)”. A PCR method 
was also used to monitor HR and SSA. DNA was extracted with the DNeasy Blood & Tisue 
Kit (Qiagen) and PCR was performed with the GoTaq® DNA Polymerase (Promega). HR 
was monitored by measuring the intensity of the amplicon generated by the primers P1 and 
P2 (Weinstock et al., 2006). SSA was monitored by measuring the intensity of the amplicon 
generated by amplification with primer F and R2 (Ochs et al., 2016, Weinstock et al., 2006). 
Both the measurements were normalized on the actin amplicon. Sequences of the primers 
are listed in table 3. Amplifications were performed using the following program and were 
determined to be in the linear range.:  
For P1-P2 primers (443-bp amplified fragment): 98 °C /5 min × 1 cycle; 98 °C /45 s, 70 °C 
/30 s, and 72 °C /30 s × 30 cycles; 72 °C/10 min × 1 cycle.  
For F-R2 primers: 98 °C /45 s × 1 cycle; 98 °C /10 s, and 50°C /30 s, 72 °C /60 s × 25 cycles; 
72 °C/2 min × 1 cycle.  
For Actin primers: 95 °C /5 min × 1 cycle; 95 °C /30 s, 62°C /30 s, and 72°C /30 s × 25 
cycles; 72 °C/10 min × 1 cycle.  
10 µl of the PCR products was loaded on a 1% agarose gel and visualized by Gel Red 
staining. Images were acquired with Chemidoc imaging system (Bio-Rad) and densitometric 
analysis was performed using the Image Lab 5.2 software.  
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2.14 Immunoblotting 
Cells were lysed in Laemmli sample buffer (2% sodium dodecyl sulphate (SDS), 10% 
glycerol, 60 mM Tris HCl pH 6.8). SDS is an anionic detergent that denatures proteins 
secondary and tertiary structures and confers a uniform negative charge to the polypeptide 
allowing electrophoretic separation of the proteins based on the molecular weight. Protein 
concentration was determined by the biochemical Lowry protein assay and the desired 
amount of protein was mixed with bromophenol blue, a dye that allows proteins tracking 
during electrophoresis. Disulfide linkages were reduced by adding Dithiothreitol (DTT) and 
proteins were further denatured by heating at 95°C for 5 minutes. Usually, 30/50 µg of whole 
cell extracts were resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE). Next, 
proteins were transferred on a nitrocellulose membrane (0,45mm) (400mA; 1h) in transfer 
buffer (25 mM Tris HCl, 0.2 M Glycine, 20% methanol). Transfer efficiency was checked 
by temporary staining with Ponceau. After blocking with 5% skim milk in TBS-T buffer 
(Tween20 0.1%) for 1 hour at RT, membranes were incubated overnight at 4oC with primary 
antibodies diluted in in 5% milk in TBS-T (see table 4). Next, membranes were washed with 
TBS-T 3 times for 10 minutes and incubated with secondary horseradish peroxidase (HRP)-
conjugated antibodies (Bio-rad) diluted in 5% milk in TBS-T. After 3 more washes with 
TBS-T, HRP activity was detected using a Chemidoc imaging system (Bio-Rad) machine 
after adding the substrate for the enhanced chemiluminescent reaction ECL (GE Healthcare). 
2.15 Immunoprecipitation 
HEK293T cells were collected and lysed in TEB150 lysis buffer (50 mM HEPES pH 7.4, 
150 mM NaCl, 2 mM MgCl2, 5 mM EGTA pH 8, 1 mM dithiothreitol (DTT), 0.5% Triton 
X-100, 10% glycerol, protease inhibitor cocktail set III (Calbiochem) and Benzonase 1:1000 
(Sigma) for 45 minutes at 4oC. Next, samples were centrifuged for 15 minutes at 16x103 g 
at 4oC and supernatant were collected. Protein concentration was determined by using the 
Bradford assay (Bio-rad). Usually, 1mg of the protein lysate was used per each 
immunoprecipitation in a reaction volume of 500 µl. As input, 1% of the immnoprecipitation 
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reaction was collected and denatured in the sample buffer (50 mM Tris-HCl pH 6.8; 2% 
SDS; 10% glycerol; 12.5 mM EDTA; 0,02 % bromophenol blue; 100 µM DTT) for 10 
minutes at 95oC. Unspecific binding of proteins to the beads was reduced by incubating 
samples with Protein G beads (50 µl) (Zymed Laboratories) for 1 hour at 4oC (pre-clearing). 
Pre-cleared samples were incubated with the indicated antibodies (see table 4) overnight at 
4oC. Next, samples were incubated with 40 µl of Protein G beads for 2h in order to allow 
antibodies binding to the beads. After 3-6 washes with lysis buffer, immunoprecipitated 
proteins were released by the addition of sample buffer and incubation at 95oC for 10 
minutes. 
2.16 Purification of Glutathione S-transferase (GST)-tagged proteins  
Purification of GST-tagged proteins exploits the affinity of GST for the glutathione ligand 
coupled to a matrix, a sepharose one for our experiments. GST-RAD51 fragments (Buisson 
et al., 2010) were transformed in Esherichia Coli BL21 and protein expression was induced 
with isopropyl β-D-1-thiogalactopyranoside (IPTG) (0,4 mM) during bacterial exponential 
growth phase (cell density 0,6-0,8 at 600nm). Upon induction, bacteria were incubated 
overnight at 20oC. Next, bacteria were collected by centrifugation for 25 minutes at 4oC and 
resuspended in lysis buffer (50mM Tris-HCl pH 7,9, 300mM KCl, 1% Triton X-100, 2mM 
DTT and protease inhibitor cocktail set III (Calbiochem) 1:200). Cells were sonicated 3 
times for 20 seconds at the amplitude of 5 impulses and power of 75%. After centrifugation 
at 20x103g at 4oC for 90 minutes, supernatants were collected and incubated with glutathione 
sepharose beads (GE Healthcare) for 2 hours at 4oC.  Next, lysates were washed for 30 
minutes at 4oC with Buffer I (PBS, 1% Triton X-100, 2mM DTT and protease inhibitor 
cocktail set III (Calbiochem) 1:200), Buffer II (300mM KCl, 50mM Tris-HCl pH 8, 2mM 
DTT and protease inhibitor cocktail set III (Calbiochem) 1:200) and Buffer III (100mM KCl, 
50mM Tris-HCl pH 8, 2mM DTT, 10% glycerol and protease inhibitor cocktail set III 
(Calbiochem) 1:200). Next, sepharose-bound proteins were aliquoted, flash-frozen in liquid 
nitrogen, and stored until use.  
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2.17 GST-pulldown 
GST-RAD51 fragments bound to sepharose beads, generated as described in section 
“Purification of Glutathione S-transferase (GST)-tagged proteins purification”, were used 
for GST-pulldowns. 1-2µg of recombinant HEK293T cells were transfected with RNase 
H2A-YFP construct (see section “plasmid transfection”) and subsequently lysed in TEB150 
buffer. Next, purified GST-RAD51 fragments were incubated with 1 mg of HEK293T cell 
lysate for 2h at 4°C. After incubation, beads were washed 4 times with TEB150 buffer, then 
resuspended in sample buffer and subjected to immunoblot analysis. 
2.18 Chromatin Immunoprecipitation (ChIP) 
Cells were cross-linked for 5.5 minutes at room temperature with Fixation Buffer (1% 
formaldehyde; 100 mM NaCl; 1 mM EDTA; 0.5 mM EGTA; 50 mM HEPES pH 7.4). Cross-
linking was quenched by addition of glycine (125 mM). Fixed cells were rinsed twice in 1X 
PBS, collected by scraping and centrifuged at 2000 rpm for 5 min at 4°C. Pellets were re-
suspended in cold B1 Buffer (0.25% Triton X-100; 1 mM EDTA; 0.5 mM EGTA; 10 mM 
Tris pH 8; Proteases inhibitors (Roche); Microcystin (Enzo Life Sciences)) by mixing for 10 
minutes on a rotating wheel at 4°C and then centrifuged at 2000 rpm for 5 minutes at 4°C. 
The same steps were repeated with cold Buffer B2 (200 mM NaCl; 1 mM EDTA; 0.5 mM 
EGTA; 10 mM Tris pH 8; Proteases inhibitors (Roche); Microcystin (Enzo Life Sciences)). 
Finally, pellets were re-suspended in a suitable volume of cold Buffer B3 (TE 1X; EGTA 
0.5 mM). Pellets were sonicated using a Focused- Ultrasonicator Covaris (duty: 5.0; PIP: 
140; cycles: 200; amplitude: 0; velocity: 0; dwell: 0; microTUBEs with AFA fiber). 
Sonicated chromatin was diluted in RIPA buffer (1% TritonX-100; 0,1% Na- Deoxycholate; 
0,1% SDS; 64 mM NaCl; 10 mM Tris HCl pH 8.0). Samples were pre-cleared for 2 hours 
on rotating wheel at 4°C by incubation with 20 µl of magnetic beads (Dynabeads® Protein 
G, LifeTechnologies). Sample were then incubated overnight rotating at 4°C with specific 
antibodies (see table 4) or no antibody (mock). The bound material was recovered by 2 hours 
incubation with 20 µl of magnetic beads per ChIP. Beads were then washed, rotating at 4°C 
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for 10 min, four times in RIPA buffer, once in LiCl buffer (250 mM LiCl; 0.5% NP-40; 
0.5% Na Deoxycholate; 1 mM EDTA; 10 mM Tris-HCl pH 8) and finally in 1X TE. ChIPed 
material was eluted by 15 min incubation at 65°C with 150 µl Elution Buffer (1% SDS; 10 
mM EDTA; 50 mM Tris HCl pH 8). Samples were reverse-crosslinked by incubation with 
proteinase K (Invitrogen) at 37°C for 5 hours and then at 65°C overnight. DNA was cleaned 
up by QIAquick PCR purification column (Qiagen) according to the manufacturer’s 
instructions and eluted in 30 ul of elution buffer (EB).  
2.19 DNA:RNA hybrids immunoprecipitation (DRIP) 
DRIP is a technique used to detect and map DNA:RNA hybrids. 5 × 106 HeLa cells were 
collected, washed with cold PBS, resuspended in 1.6 ml of Tris-EDTA (TE) buffer and 
incubated overnight with 41.5 ul of 20% SDS and 5 ul of proteinase K (Roche) at 37°C. 
DNA was extracted gently with phenol–chloroform. Briefly, after adding one volume of 
phenol-chloroform, samples were centrifuged at maximum speed for 10 minutes and the 
upper layer containing nucleic acids was precipitated by adding 1/10 volume of sodium 
acetate, 2.4 volumes of ethanol and 1 ul of glycogen. After 1 hour centrifugation at maximum 
speed at 4°C, pellets were washed twice with 70% ethanol, gently resuspended in TE1X and 
digested overnight with 50 U of HindIII, EcoRI, BsrGI, XbaI and SspI, 2 mM spermidine 
and BSA. After checking digestion, the nucleic acids were purified again with phenol–
chloroform extraction and next, as negative control, half of the DNA was treated overnight 
with RNase H (M0297; New England BioLabs). In the meantime, serum-free medium 
containing the S9.6 antibody was mixed with protein A and protein G Dynabeads 
(Invitrogen) at 4°C ON.  
Samples were purified again with phenol-chloroform extraction and 4 ug of DNA was used 
for each IP in 450 ul of TE1X and 51 ul of 10X binding buffer (10 mM NaPO4, 140 mM 
NaCl, 0.05% Triton X-100). Samples were incubated with the antibody overnight on a 
rotating wheel at 4°C. DNA–antibody complexes were washed twice with binding buffer 
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1X. DNA was eluted with 50 mM Tris-HCl pH 8.0, 10 mM EDTA, 0.5% SDS, then treated 
for 45 min with 10 ul of proteinase K at 55 °C and cleaned up with QIAquick PCR 
purification column (Qiagen) according to the manufacturer’s instructions. The indicated 
regions were amplified by RT-qPCR (see table 3 for primers sequence). The signal intensity 
plotted is the relative abundance of DNA–RNA hybrid immunoprecipitated in each region, 
normalized to input values.  
2.20 Fluorescence-activated cell sorting (FACS) 
For GFP analysis, 106 cells were fixed in 1% formaldehyde for 20 minutes on ice. Next, cells 
were washed in PBS 1% BSA and fixed in 75% ethanol. Fixed cells were washed again in 
PBS 1% BSA and stained with Propidium Iodide (PI) (Sigma-Aldrich, 50 µg/ml) in PBS 
supplemented with RNase A (Sigma-Aldrich, 250 µg/ml).  
For cell cycle analysis, 106 cells were directly fixed in 75% ethanol, as described above. 
Samples were acquired on an Attune NxT machine and analyzed with FlowJo_V10 software. 
At least 104 events were analyzed per sample. 
For sorting of HeLa-FUCCI cells, cells were collected in PBS with 2% FBS and the G1 and 
S/G2 population were sorted with a MofloAstrios (Beckman Coulter) in PBS supplemented 
with RNaseOUT (Thermo Fisher). Sorted samples were processed for DRIP as described in 
the section “DNA:RNA hybrids immunoprecipitation (DRIP)”.  
2.21 Electrophoretic mobility shift assay 
Recombinant BRCA1 and BARD1 were expressed and purified as a complex in insect cells 
by co- infection with baculoviruses. The 50 bp-long dsDNA substrate was prepared by 
annealing oligonucleotides X12-3 
(5’ GACGTCATAGACGATTACATTGCTAGGACATGCTGTCTAGAGACTATCGC3') 
and X12-4C 
(5’ GCGATAGTCTCTAGACAGCATGTCCTAGCAATGTAATCGTCTATGACGTC 3') 
as previously described (Cejka and Kowalczykowski, 2010). The 50 bp-long DNA:RNA 
hybrid substrate was prepared by annealing X12-3 DNA and X12-4C RNA. Proteins were 
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incubated for 30 minutes at 37º C with 10 nM dsDNA or DNA:RNA hybrid substrate in a 
reaction buffer containing Tris HCl (pH 7.5), 25 mM; KCl, 90 mM; EDTA (ph 8.0), 1 mM; 
DTT, 1 mM; BSA (NEB), 0.1 mg/mL; RNaseOUT (Invitrogen), 1X. Loading dye (5 μL; 
50% glycerol; Tris HCl (pH 7.5), 20 mM; EDTA, 0.5 mM; bromophenol blue) was added 
to reactions and products were separated by 6% non-denaturing polyacrylamide gel 
electrophoresis at 4 C. The gels were dried on 17CHR filter paper (Whatman), exposed to 
storage phosphor screens, and scanned by a Typhoon Phosphor imager (FLA 9500, GE 
Healthcare). Quantification of protein-bound substrates was done using Imagequant 
software. 
2.22 Statistical analysis 
Statistical analysis was performed with the unpaired two tailed Student’s t-test and 
represented as a mean ±SEM. Asterisk in the figures indicates p value <0.05.  
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3 Results 
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3.1 DNA:RNA hybrids are produced at DSBs  
We recently reported that RNA polymerase II (RNA pol II) is recruited to DSBs where it 
transcribes long non-coding RNA species, named dilncRNAs (Michelini et al., in press). 
Here, I wanted to investigate whether dilncRNAs generated at DSBs could form DNA:RNA 
hybrids and study the potential role of these hybrids in DSB repair modulation. In order to 
address this, I performed DNA:RNA hybrids immunoprecipitation (DRIP) followed by 
quantitative PCR (DRIP-qPCR) by the use of the S9.6 antibody, which specifically 
recognizes DNA:RNA hybrids. I transfected HeLa cells with the I-PpoI nuclease (Pankotai 
et al., 2012) and I monitored by DRIP-qPCR the formation of DNA:RNA hybrids upon 
damage at the I-PpoI site within the DAB1 gene, which is efficiently cut and very weakly 
transcribed in untreated HeLa cells. I observed that DSB generation induced the formation 
of DNA:RNA hybrids, within 2-4 Kb from the DSB, at both the left (figure 6b) and the right 
(figure 6c) sides of the DSB. As a specificity control, the observed signal is lost upon in vitro 
treatment with RNase H.   
 
Figure 6: DNA:RNA hybrids formation at the I-PpoI cleavage site within the DAB1 gene  
a) Schematic representation of the loci within the DAB1 gene tested for DNA:RNA hybrids formation upon I-
PpoI-mediated DSB generation b) DRIP-qPCR with the S9.6 antibody was used to monitor DNA:RNA hybrids 
accumulation in HeLa cells transfected with the nuclease I-PpoI at either the left (b) or the right (c) side of I-
PpoI cleavage site in DAB1 gene. The bar graph represents fold induction of cut samples relative to uncut. 
RNase H treatment (RH) was performed on cut samples to show specificity of the signal. Error bars represent 
s.e.m of 3 biological replicates. 
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Moreover, in order to exclude any contribution of pre-existing genic transcription, damage-
induced DNA:RNA hybrids formation was determined by DRIP-qPCR also at a distinct 
intergenic site cut by I-PpoI (figure 7), thus ruling out the possibility that DNA:RNA hybrids 
formation is the result of the annealing of a pre-existing transcript to the template genomic 
DNA. 
 
Figure 7: DNA:RNA hybrids formation at an intergenic I-PpoI cleavage site  
HeLa cells were transfected with the nuclease I-PpoI and DNA:RNA hybrids accumulation was monitored by 
DRIP-qPCR with the S9.6 antibody at an intergenic I-PpoI cleavage site. The bar graph represents fold 
induction of cut samples relative to uncut. RNase H treatment (RH) was performed on cut samples to show 
specificity of the signal. Error bars represent s.e.m of 3 biological replicates. 
 
 
To further strengthen these results, we exploited the DIvA (DSB inducible via AsiSI) cellular 
system, a clonal U2OS cell line that stably expresses the AsiSI restriction enzyme fused to 
a modified oestrogen receptor (ER) hormone-binding domain responsive to 4-hydroxy 
tamoxifen (4OHT) (Iacovoni et al., 2010). Upon treatment with 4OHT, AsiSI-ER enzyme 
translocates to the nucleus and generates DSBs at multiple genomic loci (Iannelli et al., 
2017). Only 10 to 20% of the genomic AsiSI sites are cut and the cleavage efficiency for 
each site is heterogeneous and generally lower than 50% (Iacovoni et al., 2010). DSBs 
generation upon treatment of DIva cells with 4OHT is demonstrated by representative 
images (figure 8a) and relative quantification (figure 8b) of immunofluorescence staining of 
the DDR marker γH2AX. All the quantifications of the “number of foci per cell” shown are 
generated with the automated software CellProfiler (Carpenter et al., 2006), applying an ad 
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hoc designed pipeline which recognizes and counts the number of foci in each nucleus, 
according to their size and fluorescence intensity compared to the background signal. 
 
Figure 8: Treatment of DIvA cells with 4OHT induces DSBs generation 
Treatment of DIvA cells with 4OHT induces AsiSI-ER nuclear localization and DSB generation. a) 
Representative images of DIvA cells co-stained with γH2AX and DAPI before and after 4 hours treatment with 
4OHT. b) Dot plots show the number of γH2AX foci measured using Cell Profiler software. Error bars indicate 
s.e.m. (n = 2). 
 
 
By exploiting DIvA cells, I observed DNA:RNA hybrids accumulation at non-genic DSBs 
(figure 9), thus confirming my results also in an unrelated cellular system at an additional 
genomic site. In particular, the detection of damage-induced DNA:RNA hybrids at non-
genic sites confirms that DNA:RNA hybrids formation upon damage is the result of de novo 
transcription. 
 
Figure 9: DNA:RNA hybrids formation at an intergenic AsiSI cleavage site  
DNA:RNA hybrids accumulation was monitored by DRIP-qPCR with the S9.6 antibody in DivA cells before 
and after 4 hours treatment with 4OHT. DNA:RNA hybrids formation is shown at a non-genic AsiSI-ER 
induced DSBs. The bar graph represents fold induction of cut sample relative to uncut. RNase H treatment 
(RH) was performed on cut samples to show specificity of the signal. Error bars represent s.e.m of 3 biological 
replicates. 
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Next, I attempted to recapitulate my results with imaging techniques in other cellular 
systems. First, I studied DNA:RNA hybrids formation at a specific locus in U2OS19 cells, 
a human cell line carrying an integrated plasmid containing an array of Lac- and Tet-operator 
sequences flanking the I-SceI endonuclease target site (Lemaitre et al., 2014). Binding of the 
fluorescently-tagged Lac or Tet repressor protein to the operator sequences and expression 
of the I-SceI nuclease allows visualization of the DSB site in the nucleus (figure 10a). I 
induced I-SceI expression in U2OS19 cells and I immunostained for γH2AX and DNA:RNA 
hybrids with the S9.6 antibody. As shown in figure 10b, upon I-SceI expression, γH2AX 
signal is observed at the DSB detected by focal accumulation of Cherry-LacR proteins. 
Moreover, 70% of the sites that are efficiently cut, as monitored by γH2AX signal, 
accumulate DNA:RNA hybrids (figure 10b).  
 
Figure 10: Immunofluorescence with the S9.6 antibody shows DNA:RNA hybrids formation at a site 
specific DSB 
a) Schematic representation of the U2OS19 cellular system. U2OS19 cells contain an array of Lac and Tet 
repeats flanking the I-SceI recognition site. Expression of I-SceI and of a fluorescently tagged Lac repressor 
protein (cherry-LacR) allows DSB visualization in the nucleus. b) representative images of γH2AX and S9.6 
staining in U2OS19 cells. c) Bar graph represent the % of colocalization of γH2AX and S9.6 with cherry-LacR 
(n=1)  
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I also monitored DNA:RNA hybrids accumulation upon DSB induction by using 
RNH1(D210N)-GFP, a cellular system developed in Pavel Jansak’s lab, in Zurich. 
RNH1(D210N)-GFP cells express a catalytically inactive RNase H1 that binds DNA:RNA 
hybrids but does not cut them, and it is therefore a useful tool for their detection. Moreover, 
endogenous RNase H1 levels are partially reduced by inducible expression of an shRNA 
against it. Upon irradiation, RNH1(D210N)-GFP cells accumulate γH2AX foci (figure 11a) 
and DNA:RNA hybrids, as detected by the increase in the GFP dotted pattern (figure 11a 
and b), thus confirming the results obtained with the other cellular systems.   
 
 
Figure 11: DNA:RNA hybrids form upon IR 
a) Representative images of γH2AX and GFP signal in RNH1(D210N)-GFP cells exposed or not to IR. b) dot 
plots represents the number of GFP foci per cell. Error bars represent the s.d. of 1 single experiment.  
 
 
Since dilncRNA production was shown to be dependent on RNA pol II (Michelini et al., in 
press), I next monitored whether treatment with the RNA pol II inhibitor 5,6-dichloro-1-β-
D-ribofuranosylbenzimidazole (DRB) affected DNA:RNA hybrids generation. To test this 
hypothesis, I performed DRIP-qPCR at the I-PpoI cleavage site within the DAB1 gene in 
HeLa cells treated with DRB or with vehicle prior to DSB induction. While DNA:RNA 
hybrids formed upon damage in vehicle-treated cells, they did not accumulate at the 
damaged locus when RNA pol II activity was inhibited by treatment with DRB (figure 12), 
thus confirming that DNA:RNA hybrids formation upon damage requires RNA pol II 
activity.  
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Figure 12: DNA:RNA hybrids formation depends on RNA pol II activity 
HeLa cells were treated with DMSO or DRB for 2 hours and next I-PpoI induction was induced for 1.5 hours. 
DNA:RNA hybrids accumulation was measured by DRIP-qPCR with the S9.6 antibody at the I-PpoI cleavage 
site within the DAB1 gene. The bar graph represents fold induction of cut samples relative to uncut. Error bars 
represent s.e.m of 3 biological replicate. 
 
Altogether these results show, in different cellular systems and by different techniques, that 
DNA:RNA hybrids accumulate at DSBs and that their formation is dependent on RNA pol 
II transcription.  
3.1.1 Damage-induced DNA:RNA hybrids form preferentially during the S/G2 cell cycle 
phase 
Once established that DNA:RNA hybrids are formed at DSBs in different cellular systems 
and at different genomic locations, I wanted to test whether DNA:RNA hybrids form 
preferentially during a specific cell-cycle phase. For this purpose, I took advantage of HeLa 
cells expressing the fluorescent ubiquitination-based cell cycle indicator (FUCCI) (Sakaue-
Sawano et al., 2008). The FUCCI sensor consists of a fluorescent protein-based system that 
employs a green (GFP) and a red (RFP) fluorescent protein, respectively fused to the cell 
cycle regulators GEMININ and CDT1. Temporal regulation of GEMININ and CDT1 
ubiquitylation determines their selective proteasomal degradation. Therefore, nuclei appear 
red when GEMININ-GFP is degraded (G1 phase) and green when CDT1-RFP is degraded 
(S/G2 phase). I sorted the G1 and S/G2 populations and I monitored in each one of them the 
accumulation of DNA:RNA hybrids at the I-PpoI cleavage site within the DAB1 gene. I 
observed that upon DSB induction, DNA:RNA hybrids accumulate preferentially in the 
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S/G2 phase of the cell cycle (figure 13). The complete loss of signal upon in vitro treatment 
with RNase H demonstrates its specificity.  
 
Figure 13: DNA:RNA hybrids form preferentially during S/G2 cell cycle phase 
G1 and S/G2 phase I-PpoI transfected HeLa-FUCCI cells were sorted and DRIP-qPCR analysis was performed 
with the S9.6 antibody. The bar graph represents fold induction of cut samples relative to uncut. RNase H 
treatment (RH) was performed on cut G1 and S/G2 samples to show specificity of the signal. Error bars 
represent s.e.m of 3 biological replicate. 
 
Next, I tried to recapitulate this result at the site-specific DSB inducible in U2OS19 cells as 
described above. As already mentioned, U2OS19 cells contain an array of Lac and Tet 
repeats flanking the I-SceI target site. Accumulation of a fluorescently-tagged Lac repressor 
protein and I-SceI expression allows DSB site visualization. Since the S9.6 staining could 
not be coupled with staining for cyclin A, which is the marker of S/G2 phase cells, I used as 
a tool for DNA:RNA hybrids detection the HB-GFP, which is the GFP-tagged DNA–RNA 
hybrid-binding (HB) domain of the RNase H1, that only binds DNA:RNA hybrids but does 
not cut them (Bhatia et al., 2014). I induced I-SceI expression in U2OS19 cells transfected 
with HB-GFP and I immunostained for γH2AX and cyclin A, to detect S/G2 phase cells. As 
shown in figure 14, DNA:RNA hybrids levels at the locus studied decrease upon damage in 
G1 phase cells, while they increase in S/G2 cells, thus confirming DNA:RNA hybrids 
accumulation at DSBs specifically in S/G2 phase cells.  
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Figure 14: Imaging analysis confirms DNA:RNA hybrids formation at a site-specific DSB in S/G2 phase 
cells  
a) Representative images of cherry-LacR and HB-GFP fluorescent signal and cyclin A staining of U2OS19 
cells. b) Bar graph represent the % of colocalization of HB-GFP with cherry-LacR (n=1) 
 
In order to strengthen these results, we established a collaboration with Eli Rothenberg’s 
group at NYU and his postdoc Donna Whelan, who performed super-resolution imaging 
analysis on G1- and S/G2-synchronized U2OS cells treated with the radiomimetic drug 
Neocarzinostatin (NCS), which generates DSBs by free radical attack on DNA. We 
monitored the colocalization of DNA:RNA hybrids, visualized with the S9.6 antibody, with 
the DSB marker γH2AX in G1 and S phase NCS-treated U2OS cells. An increase in the 
colocalization events in S phase cells compared to G1 phase cells was observed (figure 15).  
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Figure 15: DNA:RNA hybrids and γH2AX colocalize preferentially in NCS-treated S phase cells 
a) Representative images of γH2AX (cyan) –DNA:RNA hybrids (magenta) colocalization in NCS treated S 
phase U2OS cells. b) dot plot represents the number of γH2AX and DNA:RNA hybrids colocalization in G1 
and S phase cells relative to random (>50 cells, n=3).  
 
 
Next, under the same super-resolution settings, DNA:RNA hybrids were studied for their 
colocalization with the HR proteins BRCA1 and RAD51. Indeed, we observed an increase 
in the colocalization of DNA:RNA hybrids with BRCA1 and RAD51 in NCS-treated S 
phase cells (figure 16). 
 
 
Figure 16: DNA:RNA hybrids colocalize with BRCA1 and RAD51 in NCS-treated S phase cells 
a) Representative images of BRCA1 (cyan), DNA:RNA hybrids (yellow), RAD51 (magenta) colocalization in 
NCS treated S phase U2OS cells. Dot plot represents the number of DNA:RNA hybrids and either BRCA1 (b) 
or RAD51 (c) colocalization in DMSO or NCS-treated S phase U2OS cells relative to random (>50 cells, n=3).  
 
Altogether, my data and data generated in a different lab with an independent experimental 
setup (super-resolution microscopy on NCS-treated cells) confirm that DNA:RNA hybrids 
form at DSBs preferentially during the S/G2 cell cycle phase.   
3.1.2 DNA end resection favors the formation of damage-induced DNA:RNA hybrids  
In the light of the preferential accumulation of damage-induced DNA:RNA hybrids at DSBs 
during the S/G2 phase of the cell cycle, I tested the impact of DNA end resection on 
DNA:RNA hybrids formation. To test this hypothesis I knocked-down CtIP in HeLa cells 
γH2AX (cyan)/S9.6 (yellow)
a b γH2AX-S9.6
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and I monitored DNA:RNA hybrids accumulation at the I-PpoI cleavage site within the 
DAB1 gene at three time-points after cut. I observed that impairment of DNA end resection 
prevented DNA:RNA hybrids formation in all the time-points analysed (figure 14).  
 
Figure 14: DNA end resection facilitates DNA:RNA hybrid formation at DSBs 
HeLa cells were depleted for CtIP by RNAi. 48 hours later, I-PpoI was transfected and DSB generation was 
induced the day after for 40, 80 and 120 minutes. DRIP experiment was performed with the S9.6 antibody. 
The bar graph represents fold induction of cut samples relative to uncut. RNase H treatment (RH) was 
performed on cut samples to show specificity of the signal. Error bars represent s.e.m of 3 biological replicate  
 
 
Importantly, I observed that CtIP knock-down, whose extent is shown in figure 15a, did not 
strongly alter cell cycle distribution (figure 15b), a parameter that could affect my analyses, 
being DNA:RNA hybrids accumulation restricted to the S/G2 cell cycle phase, as previously 
shown.  
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Figure 15: CtIP depletion does not affect cell cycle distribution 
qPCR analysis of CtIP mRNA levels in HeLa cells transfected with siRNAs against CtIP for 72 hours (a). 
FACS analysis (b) and relative quantification (c) of cell cycle distribution of HeLa cells untreated or depleted 
for CtIP. 
 
Next, I wanted to test whether proteins involved in HR also affected damage-induced 
DNA:RNA hybrids accumulation. For this reason, I depleted by RNAi BRCA2 and RAD51 
in HeLa cells (figure 16a) and I first monitored the impact of the knock-down on the cell 
cycle. Cell cycle profiling of BRCA2 and RAD51 depleted HeLa cells revealed cell cycle 
changes that discouraged me from using this setup for these analysis (figure 16b) and 
prevented me to obtain conclusive results. 
Altogether, this set of results shows that RNA pol II transcripts, most likely dilncRNAs, 
form DNA:RNA hybrids at DSBs, preferentially on resected DNA ends generated during 
the S/G2 phases of the cell cycle. 
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Figure 16: BRCA2 and RAD51 depletion affect cell cycle distribution 
qPCR analysis of BRCA2 or RAD51 mRNA levels in HeLa cells transfected with siRNAs against BRCA2 or 
RAD51 for 72 hours (a) FACS analysis (b) and relative quantification (c) of cell cycle distribution of HeLa 
cells untreated or depleted for BRCA2 or RAD51. 
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3.2 RNA participates in HR proteins recruitment to DSB 
3.2.1 Inhibition of RNA pol II transcription impairs HR proteins foci formation 
Once demonstrated that DSB-induced RNA pol II-mediated de novo transcription generates 
DNA:RNA hybrids at DSBs in S/G2 phase, I proceeded to study the impact of transcriptional 
inhibition on focal accumulation of HR proteins. In order to test this, I took advantage of 
two drugs, α-amanitin and DRB, that inhibit RNA Pol-II transcription in two different ways: 
α-amanitin binds RNA pol II, blocks RNA synthesis and triggers RNA pol II degradation; 
DRB inhibits RNA pol II elongation by targeting mainly CDK9 and inhibiting CDK9-
mediated phosphorylation of RNA pol II C-terminal domain (CTD) during transcription 
(Bushnell et al., 2002, Nguyen et al., 1996). HeLa cells were irradiated and, immediately 
after, treated with α-amanitin or DRB, or vehicles. 6 hours later cells were fixed and stained 
for the HR proteins BRCA1, BRCA2, and RAD51. BRCA1 and RAD51 foci were co-stained 
together with cyclin A, in order to selectively detect S/G2-positive cells and avoid 
misleading interpretations of results due to potential cell-cycle variations. For technical 
reasons, BRCA2 staining could not be coupled with cyclin A staining, and CENP-F, a 
marker of G2 phase, was instead used. The inhibition of RNA pol II was confirmed by 
monitoring by qRT-PCR the level of Fos, a short half-life RNA pol II transcript (figure 17).  
 
Figure 17: Efficacy of RNA pol II-mediated transcription inhibition 
Efficiency of α-amanitin (a) and DRB (b) treatment monitored by qRT-PCR analysis of the levels of FOS, a 
short-lived RNA pol II transcript.  
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Strikingly, RNA pol II inhibition with either α-amanitin (figure 18a) or DRB (figure 18c) 
strongly impaired the formation of BRCA1, BRCA2, and RAD51 foci, as also shown in the 
relative quantifications (figure 18b and 18d), while not impacting on their protein levels 
(figure 20). Next, we monitored the impact of RNA pol II inhibition on DNA end resection 
by probing for the ssDNA binding protein RPA, the DNA damage-induced phosphorylated 
form of the RPA2 subunit on Ser-4 and Ser-8 (p-RPA Ser4/8), and by directly determining 
ssDNA by BrdU native staining – cells incubated in the presence of BrdU were stained under 
native conditions with an antibody against BrdU that detects only extensive stretches of 
ssDNA. ssDNA by BrdU native staining, RPA, and p-RPA Ser 4/8 stainings (figure 19) 
revealed no reduction of DNA end resection upon RNA pol II inhibition, rather suggested a 
moderate increase. Also in these experiments, S/G2 phase cells were selected by co-staining 
with cyclin A.  
This set of results shows that, although DNA end resection is not reduced, actually 
moderately increased, the recruitment of HR proteins, including BRCA1, BRCA2 and 
RAD51, is strongly abolished upon RNA pol II inhibition, suggesting a possible role for 
RNA in the recruitment of these proteins. 
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Figure 18: Inhibition of RNA pol II transcription impairs HR proteins foci formation 
HeLa cells were treated with α-amanitin (a) or DRB (c), or relative vehicles, and irradiated in parallel. 6 hours 
later cells were fixed and stained for BRCA1, BRCA2, and RAD51. BRCA1 and BRCA2 staining was coupled 
with cyclin A, to detect the S/G2 phase cells. BRCA2 staining was coupled with CENP-F, a marker of G2 
phase cells. Dot plots of α-amanitin (b) or DRB (d) treated cells represent the number of foci in each nucleus. 
Error bars indicate s.e.m. (n ≥ 3). 
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Figure 19: Inhibition of RNA pol II transcription mildly increases DNA end resection 
HeLa cells were treated with α-amanitin (a) or DRB (c), or relative vehicles, and irradiated in parallel. 6 hours 
later cells were fixed and resected DNA ends were visualized by BrdU native staining, RPA, and p-RPA Ser 
4/8 staining. Co-staining with cyclin A, allowed to distinguish the S/G2 phase cells. Dot plots of α-amanitin 
(b) or DRB (b) treated cells represent the number of foci in each nucleus. Error bars indicate s.e.m. (n ≥ 3). 
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Figure 20: Inhibition of RNA pol II transcription does not affect the level of key HR proteins  
Representative immunoblot of control or irradiated HeLa cells treated with α-amanitin (a) or DRB (b) or 
vehicles (n=2) 
 
3.2.2 Inactivation of dilncRNAs with complementary ASOs inhibits HR 
The results previously described show that active transcription is necessary for HR foci 
formation but do not demonstrate a direct role and sequence-specificity of damage-induced 
RNAs in this process. According to recent results obtained in our laboratory, four different 
RNA species are generated from a DSB: two transcribed in opposite orientations away from 
each end of the DSB (dilncRNAs from) and two synthetized toward the DSB (dilncRNAs 
to) (Michelini et al., in press) (figure 21a). In order to test whether RNAs with the sequence 
of the damaged locus were specifically necessary for HR, we took advantage of a well-
known system to study homology-directed repair, the DR-GFP system (Pierce et al., 1999). 
TRI-DR-U2OS cells contain two non-functional GFP sequences: a sceGFP containing an I-
SceI recognition site, which also acts as a stop codon for GFP expression, and a truncated 
GFP (see figure 21a). Upon induction of I-SceI expression and DSBs formation, only HR 
between the two non-functional GFP sequences results in the formation of the correct GFP 
sequence coding for GFP. HR can be monitored by either evaluation of GFP expression by 
FACS analysis, or, more directly, by PCR amplification of the functional GFP genomic 
DNA sequence generated upon recombination. In order to inhibit the action of dilncRNAs 
generated upon cut, I designed Antisense Oligonucleotides (ASOs) complementary to 
dilncRNAs. In particular, I used Locked Nucleic Acids (LNAs), modified RNA species that 
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bind the endogenous complementary RNAs and inhibit their functions, as depicted in figure 
21a. I transfected different set of ASOs matching the dilncRNAs potentially produced from 
the damaged I-SceI locus and I induced in parallel the expression of I-SceI, generating a 
DSB at the I-SceI locus. 72 hours after transfection, I monitored HR by FACS analysis of 
GFP expression (with the help of Corey Jones-Weinert in the laboratory) and by directly 
measuring the recombination event by PCR on genomic DNA.  
 
Figure 21: dilncRNAs inactivation by complementary ASOs inhibits HR  
a) Use of DR-GFP system to monitor HR (Pierce, 1999). Engineered TRI-DR-U2OS cells contain two non-
functional GFP sequences: a sceGFP containing an I-SceI recognition site, that is also a stop codon for GFP 
expression, and a truncated GFP. Upon induction of I-SceI expression and DSBs formation, HR between the 
two non-functional GFP sequences restores the correct GFP sequence, coding for a functional GFP, which 
expression can be monitored by FACS analysis. Upon damage, dilncRNAs are transcribed bi-directionally 
from (dilncRNAs from) and toward (dilncRNAs to) the DSB (Michelini et al., in press). For each dilncRNAs, 
5 matching Antisense Synthetic Oligonucleotides (ASOs) were used: ASOs pool A and B match the dilncRNA 
from on the right and on the left part of the DSB, respectively; ASOs pool RA and RB match the dilncRNA to 
on the right and on the left part of the DSB, respectively. b) FACS analysis of HR efficiency. TRI-DR-U2OS 
cells were transfected with 20 nM pool of ASOs in different combinations: A/B, RA/RB, and All. In parallel, 
I-SceI expression was induced by adding 5 µg/ml doxycycline. 24 hours after, GFP expression was measured 
by FACS. Dot plots represent 3 independent experiment and error bars indicate s.e.m. 
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As shown in figure 21b, upon I-SceI induction and DSB generation 10% of the cells 
transfected with a control ASO matching an unrelated sequence undergo efficient HR and 
express GFP. Treatment with ASOs matching either the dilncRNAs from or to reduces GFP 
expression. As a control, treatment with ASOs that match dilncRNAs from or to but have 
been inactivated by annealing to each other (All) does not reduce HR efficiency. 
Importantly, treatment with ASOs did not cause cell cycle alterations, that could be 
responsible for a different HR efficiency among the samples (figure 22). In order to further 
confirm the impact of ASOs on HR, I performed PCR on genomic DNA with primers that 
only amplify the GFP sequence resulting from HR between the two mutated GFPs (see figure 
23a). I observed that treatment with ASOs matching dilncRNAs, but not with control ASOs, 
strongly reduces HR between the two GFP sequences (figure 23b), thus confirming the 
impact of ASOs on this repair pathway.   
 
 
 
Figure 22: Treatment with ASOs targeting dilncRNAs does not affect cell cycle distribution  
FACS analysis of cell cycle distribution of TRI-DR-U2OS cells transfected for 24 hours with 20 nM pool of 
ASOs in different combinations: A/B, RA/RB, and All. In parallel with ASOs transfection, I-SceI expression 
is obtained by adding 5 µg/ml doxycycline.   
 
Importantly, PCR on genomic DNA also allows to monitor SSA in the same reporter system. 
SSA is the result of over-resection of the broken DNA ends and RAD52-mediated annealing 
of long-tract homology sequences on the exposed resected ends. This process requires DNA 
end resection but not the recombinase RAD51. As shown in figure 23c, treatment with ASOs 
matching dilncRNAs from or to did not inhibit SSA. These results indicate that dilncRNAs 
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inactivation by complementary ASOs does not impact on DNA end resection, an event 
required for both HR and SSA, but it only impairs the unique steps of HR.  
 
Figure 23: dilncRNAs inactivation by complementary ASOs inhibits HR but not SSA   
a) Schematic representation of the ASOs used to block dilncRNAs and the primers used to detect homologous 
recombination (HR) and single strand annealing (SSA). ASOs A and B target the dilncRNAs from, respectively 
on the right and on the left side of the DSBs. ASOs RA and RB target the dilncRNAs to, respectively on the 
right and on the left side of the DSBs. HR and SSA are two of the possible HDR-based mechanisms to repair 
the I-SceI induced DSB. Upon HR, the correct GFP sequence containing the 5’ portion of the truncated GFP 
and the 3’ of the sceGFP is generated. The HR product can be amplified by PCR using one primer matching 
the 5’ part of the truncated GFP (P1) and one primer matching the 3’ part of the sceGFP (P2). Over-resection 
of the exposed DNA ends results in SSA and generates a 0.8 kb amplicon when PCR with a primer matching 
a region upstream to the sceGFP (F1) and a primer matching a region downstream of the truncated GFP (R2) 
are used. b) HR efficiency analyzed by genomic semi-quantitative PCR with primers P1 and P2. c) SSA 
efficiency analyzed by genomic semi-quantitative PCR with primers F1 and R2. Error bars show the s.e.m. of 
2 independent experiments.   
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3.2.3 RNA species, possibly in the form of DNA:RNA hybrids, contribute to BRCA1 
recruitment to DSBs 
To confirm the direct role of RNA in HR, I monitored the effect of RNase A or RNase H 
treatment on HR foci. In particular, I treated irradiated permeabilized U2OS cells with 
RNase A o RNase H before fixation in order to remove all RNAs in the cells, including 
dilncRNAs generated upon damage, and DNA:RNA hybrids, respectively. Only after 
treatment, I fixed and stained for HR factors. I observed that RNase A, as well as RNase H 
treatment, dismantled BRCA1 foci (figure 24). The same treatment revealed no reduced, if 
any moderately increased, DNA end resection signals, as monitored by BrdU and RPA 
stainings (figure 25a and b). 
 
Figure 24: BRCA1 foci are dismantled by treatment with RNase A and RNase H 
U2OS irradiated cells were permeabilized and treated with RNase A or RNase H prior to fixation. 
Representative images (a) and quantification (b) of BRCA1 and cyclin A co-staining of irradiated cells treated 
with PBS only, RNase A and RNase H. Error bars indicate s.e.m. (n = 3). 
 
 
Figure 25: RNase A and RNase H treatment mildly increases BrdU and RPA signal 
HeLa and U2OS irradiated cells were permeabilized and treated with RNase A or RNase H prior to fixation. 
Dot plots of RPA and BrdU foci in irradiated U2OS cells treated with PBS only, RNase A and RNase H. Error 
bars indicate s.d. of 1 experiment.   
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In order to further confirm the results obtained with RNase H treatment on permeabilized 
cells, I overexpressed a GFP tagged RNase H1 in U2OS cells. As shown in figure 26, RNase 
H1 overexpression impairs BRCA1 foci formation, thus confirming the role of DNA:RNA 
hybrids in favoring BRCA1 recruitment. However, RAD51 foci formation was not impaired 
upon RNase H1 overexpression, suggesting that in the absence of DNA:RNA hybrids the 
loading of RAD51 is not strongly dependent on BRCA1.  
 
Figure 26: RNase H overexpression impairs BRCA1 but not RAD51 foci formation 
U2OS cells overexpressing a control GFP or GFP-RNase H1 were irradiated with 2Gy and fixed 1 hour and 6 
hours later. Representative images (a) and relative quantification (b) of BRCA1 foci and representative images 
(a) and relative quantification (b) of RAD51 foci are shown. Dot plots of represent the number of foci in each 
nucleus. Error bars indicate s.e.m. (n = 3). 
 
In line with this result, the efficiency of HR-mediated repair, as monitored by GFP 
expression in the DR-GFP system, is not affected by RNase H1 overexpression (figure 27). 
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Figure 27: RNase H1 overexpression does not affect HR 
TRI-DR-U2OS cells were transfected with RNase H1 and in parallel I-SceI expression was induced by adding 
doxycycline to the cell medium.  48 hours later GFP expression was monitored by FACS analysis. Error bars 
indicate s.e.m. (n = 3). 
 
3.2.4 BRCA1 binds in vitro dsDNA and DNA:RNA hybrids 
Having observed that BRCA1 recruitment to DSB is affected by inhibition of RNA pol II 
transcription, as well as RNase A and RNase H treatment, and RNase H1 overexpression, 
we tested whether BRCA1 could bind to DNA:RNA hybrids. In order to address this we 
collaborated with Petr Cejka’s lab in Bellinzona and his postdoc Sean Michael Howard, who 
performed electrophoretic mobility shift assay (EMSA) of purified recombinant BRCA1 and 
BRCA1-BARD1 heterodimer in the presence of DNA duplexes or DNA:RNA hybrids. 
Radioactively labelled DNA duplexes or DNA:RNA hybrids were incubated with 
recombinant proteins and separated by electrophoresis on a native polyacrylamide gel. As 
shown in figure 28a, when nucleic acids were not incubated with recombinant proteins a fast 
migrating band corresponding to the free nucleic acids was observed. The incubation of 
nucleic acids with increasing concentrations of either BRCA1 (figure 28a) or BRCA1-
BARD1 constitutive heterodimer (figure 28b) determined a “band-shift”, indicating protein 
interaction with the tested nucleic acids. As shown in figure 28a and in the quantification of 
percentage of free substrate (figure 28c), BRCA1 alone binds DNA:RNA hybrids with an 
affinity slightly higher compared to DNA duplexes. The constitutive heterodimer BRCA1-
BARD1 binds DNA:RNA hybrids to a similar affinity compared to DNA duplexes (figure 
28b).    
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Figure 28: BRCA1 and BRCA1-BARD1 complex bind DNA:RNA hybrids in vitro  
Different concentrations of the recombinant BRCA1 and BARD1 proteins were incubated with radioactively 
labelled dsDNA (a) or DNA:RNA hybrids (b) substrates and separated on a non-denaturing polyacrylamide 
gel. The graph represents the % of substrate bound at different proteins concentration (c).  
 
  
nM:                 30    60    100  150            30     60    100  150   
BRCA1 BRCA1-BARD1
Free substrate
Protein-bound D
N
A 
N
o 
pr
ot
ei
n
N
o 
pr
ot
ei
n
*
nM:              30     60    100  150              30    60    100   150   
BRCA1 BRCA1-BARD1
*
N
o 
pr
ot
ei
n
N
o 
pr
ot
ei
n
*
Free substrate
Protein-bound D
N
A 
DNA:DNA DNA:RNAa b
c
0 50 100 150
0
20
40
60
80
100
nM Protein
%
 S
ub
st
ra
te
 B
ou
nd
BRCA1 DNA
BRCA1-BARD1 DNA
BRCA1 RNA
BRCA1-BARD1 RNA
	84	
3.3 RNase H2 is recruited to DSBs and interacts with HR proteins 
3.3.1 RNase H1 depletion cannot be obtained by siRNA transfection  
To gain further insight into the role of DNA:RNA hybrids on HR modulation, I tried to 
deplete the two enzymes with RNase H activities in the cell: RNase H1 and RNase H2. I 
could not deplete RNase H1 since RNase H1 knock-down performed with a pool of 
commercial siRNA was not efficacious in my hands. Indeed, RNase H1 protein levels did 
not change reproducibly upon transfection with a pool of different siRNA in several tested 
conditions. To exclude that the result observed was due technical problems, I tested the 
specificity of the antibody by western-blot analysis. In particular, I over-expressed a GFP-
tagged RNase H1 and I used siRNAs against either GFP or RNase H1. As shown in figure 
29, siGFP transfection reduces the GFP-RNase H1 levels, as detected with the RNase H1 
antibody, thus showing that the antibody used specifically recognize the RNase H1. 
However, only a moderate decrease in GFP-RNase H1 level and no decrease in the 
endogenous RNase H1 level is observed upon siRNase H1 transfection. From this result I 
concluded that, although the antibody was specific, no efficient RNase H1 depletion could 
be obtained with the tools available in the lab.  
 
Figure 29: RNase H1 is not depleted upon siRNA transfection  
U2OS cells were transfected with 20 nM siRNAs matching luciferase, GFP, and RNase H1 and the day after 
they were transfected with plasmids expressing GFP or GFP-RNase H1. Immunoblot and relative 
quantification are shown (n=1)  
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3.3.2 RNase H2 depletion inhibits HR by impacting on key HR proteins level  
I next tested the depletion of RNase H2, the major RNase H activity in mammalian nuclei. 
RNase H2 depletion was obtained by using siRNAs directed against RNase H2A, the 
catalytic subunit of the trimeric complex RNase H2, since it is known that depletion of one 
of the three subunits destabilizes the complex (Cerritelli and Crouch, 2009). The impact of 
RNase H2 depletion on HR-mediated repair was monitored by using the DR-GFP system 
(see figure 21a). I transfected TRI-DR-U2OS cells either with siRNA against RNase H2A 
or against BRCA2, as a positive control, and in parallel I induced I-SceI expression. Three 
days after, I monitored HR efficiency by both FACS analysis (figure 30a) and genomic DNA 
PCR (figure 30b). As shown in figure 30a, upon I-SceI expression, the percentage of GFP-
positive cells increases in control cells, while a very low increase is observed in cut cells 
lacking BRCA2. Interestingly, in RNase H2A-depleted cut cells the percentage of GFP 
positive cells is lower than in the positive control. This result is further confirmed by PCR 
on genomic DNA. Upon I-SceI expression, a band corresponding to the amplicon generated 
upon HR (see figure 23a) is observed in the control sample (figure 30b). Instead, the intensity 
of the band corresponding to the recombination product is lower in both BRCA2 and RNase 
H2A-depleted samples, thus confirming the results obtained with FACS analyses. 
 
Figure 30: RNase H2 depletion impairs HR as monitored by the DR-GFP system  
TRI-DR-U2OS cells were transfected for 72 hours with siRNAs matching a control sequence, RNase H2A, 
and BRCA2 and in parallel I-SceI expression was induced with doxycycline. HR efficiency monitored by 
FACS analysis (a) or semi-quantitative PCR on genomic DNA (see figure 23a) (b) in TRI-DR-U2OS cells 
transfected with siRNA targeting RNase H2A and BRCA1 (n=3)  
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However, when I tested the efficiency of RNase H2 depletion by either qRT-PCR (figure 
31a) and WB analysis (figure 31b), I observed that siRNase H2A not only reduced the RNase 
H2A levels, but also the levels of key HR proteins, including BRCA1, BRCA2, and RAD51.  
 
Figure 31: RNase H2 depletion reduces HR proteins levels 
mRNA (a) and protein (b) levels of the key HR proteins as monitored, respectively, by qRT-PCR and 
western blot analysis. (RH2A = RNase H2A) 
 
 
Since I thought that the reduction in the HR protein level upon RNase H2A siRNA 
transfection could be due to an off-target effect of the siRNAs used, I deconvolved the 
siRNAs pool used in the previous RNase H2A depletion experiment and I tested the 
expression of BRCA2 by qRT-PCR with three different primers pairs matching the 5’-, 
middle-, and 3’-region of the transcript, to exclude that alternative transcripts were generated 
upon RNase H2A depletion (figure 32). I observed, that each one of the siRNA used not 
only reduced RNase H2 levels but also BRCA2 levels, as monitored by qRT-PCR (figure 
32a) and immunoblot analysis (figure 32b). From these results it can be concluded that 
RNase H2 depletion negatively affect HR by reducing the levels of key HR proteins. 
Although potentially of some interest, as it suggests that RNase H2 and potentially 
DNA:RNA hybrids are controlling gene expression of HR genes, this result prevented me to 
use RNase H2 depletion as a tool to modulate DNA:RNA hybrids levels at DSBs.  
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Figure 32: Impact of RNase H2A depletion on BRCA2 expression is not due to siRNA off-target effect 
BRCA2 mRNA (a) and protein (b) levels as monitored, respectively, by qRT-PCR using 3 different primers 
pairs matching the 5’ (start), middle, and 3’ (end)-region of the transcript and western blot analysis. (RH2A = 
RNase H2A). 
 
3.3.3 RNase H2 is recruited to DSBs  
Having observed that DNA:RNA hybrids form at DSBs, I monitored whether protein 
responsible for their degradation were recruited to DSBs. In mammalian cells two proteins 
with RNase H activities have been characterized: RNase H1, which is mainly cytoplasmic, 
and RNase H2, which is mainly nuclear and represents the major RNase H activity in the 
cell (Cerritelli and Crouch, 2009). Thus, I tested whether RNase H2 was recruited to DSBs. 
I thus performed immunofluorescence stainings for all the three RNase H2 subunits on either 
untreated or irradiated U2OS cells, but I could only detect a pan-nuclear signal in both 
conditions. I therefore decided to exploit in situ proximity ligation assay (PLA), a technique 
that allows in situ visualization of proximity between two proteins of interest: when two 
proteins interact or are in close proximity (<40 nm) a signal detectable by fluorescence 
microscopy is generated. By performing PLA between RNase H2A and γH2AX in untreated 
and irradiated U2OS cell fixed 1 or 6 hours after irradiation, I observed an increase in PLA 
signal in irradiated cells compared to not irradiated (figure 33), thus indicating RNase H2A 
proximity with γH2AX. 
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Figure 33: PLA reveals proximity between RNase H2A and γH2AX 
PLA between RNase H2A and γH2AX was performed on U2OS cells untreated or irradiated 2Gy and fixed 1 
and 6 hours later. Dot plots represent the number of PLA dots per cell and error bars are s.e.m from 3 
independent experiments. 
 
To further confirm RNase H2A recruitment to DSBs, I performed Chromatin 
immunoprecipitation (ChIP) with antibodies against RNase H2A and BRCA1, as a positive 
control, followed by qPCR amplification of the regions close to the DSB in the DR-GFP 
system. As already mentioned, in the DR-GFP cells a mutated GFP sequence contains the 
recognition site for the I-SceI nuclease, whose expression can be induced upon doxycycline 
administration. As expected, 16 hours upon doxycycline treatment, BRCA1 localizes to the 
damaged locus (figure 34b). Similarly, RNase H2A accumulates at the DSB, at levels 
comparable with BRCA1 (figure 34a) 
 
Figure 34: ChIP analysis shows RNase H2A recruitment to DSBs 
Accumulation of RNase H2A (a) and BRCA1 (b) as detected by ChIP-qPCR at the I-SceI cleavage site in the 
DR-GFP system (see figure 23a). The bar plot show the fold induction relative to the uncut (n=3).  
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3.3.4 RNase H2 recruitment to DSBs is cell-cycle regulated 
Since DRIP analysis showed a preferential accumulation of damage-induced DNA:RNA 
hybrids in S/G2 cell cycle phases, I wanted to test whether also RNase H2A recruitment was 
cell cycle regulated. For this reason, I performed PLA between γH2AX and either the RNase 
H2A (by using two different antibodies (Ab-1 and Ab-2)) or the RNase H2B subunits of 
RNase H2 in untreated or irradiated HeLa-FUCCI cells, in order to distinguish the different 
cell-cycle phases. I observed that the PLA signal, indicating proximity between γH2AX and 
each one of the RNase H2 subunits tested, was moderately higher in undamaged S/G2 phase 
cells compared to G1 cells (figure 35). However, while only a mild increase in PLA signal 
was observed in damaged G1 cells compared to the undamaged ones, a more pronounced 
increase in PLA signal was observed for damaged S/G2 cells compared to undamaged ones, 
with all the antibodies combinations tested.  
 
Figure 35: PLA reveals preferential γH2AX-RNase H2 interaction during S/G2 phase 
PLA between γH2AX and either RNase H2A, detected with two different antibodies (a and b), and RNase H2B 
(c), was performed on HeLa-FUCCI cells not irradiated or irradiated 2Gy and fixed 6 hours later. Dot plots 
represent the number of PLA dots per cell and error bars are s.e.m from 3 independent experiments.  
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These results indicate that RNase H2 localize to DSBs preferentially during S/G2 phase of 
the cell cycle and they are not biased by variations of γH2AX foci or RNase H2 protein level 
during the cell cycle phases analyzed, as demonstrated by the unaltered number of γH2AX 
foci (figure 36a and b) and the unchanged RNase H2A and RNase H2B pan-nuclear signals 
(figure 36c) in G1 and S/G2 HeLa-FUCCI cells.   
 
Figure 36: RNase H2 and γH2AX levels are comparable during G1 and S/G2 cell cycle phase 
Immunofluorescence analysis was performed on not irradiated and irradiated HeLa-FUCCI cells stained for 
γH2AX (a), RNase H2A, detected with two different antibodies (b and c), and RNase H2B (d). The dot plot 
represents the number of foci per nucleus. The bar graphs represent the mean nuclear intensity. Error bars are 
s.e.m from 2 independent experiments.  
  
Since PLA analyses suggested RNase H2 recruitment to DSBs preferentially during S/G2 
cell cycle phase, in collaboration with Eli Rothenberg’s group at NYU and his postdoc 
Donna Whelan, we monitored RNase H2A recruitment to DSBs by super-resolution 
microscopy throughout the cell cycle. In order to test this, we treated G1 and S/G2 
synchronized U2OS cells with the radiomimetic drug NCS and immunostained them for 
γH2AX and RNase H2A. As shown in figure 37, RNase H2A colocalizes with γH2AX 
preferentially in S phase damaged cells.  
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Figure 37: γH2AX and RNase H2A colocalize preferentially in NCS-treated S phase cells 
a) Representative images of γH2AX (cyan)-RNase H2A (magenta) colocalization in NCS treated S phase 
U2OS cells. b) dot plot represents the number of γH2AX and RNase H2A colocalization in G1 and S phase 
cells relative to random (>50 cells, n=3).  
 
Overall these results, generated through several different techniques and also in 
collaboration with another lab, consistently indicate that RNase H2 is recruited to DSBs 
preferentially during S/G2 phase of the cell cycle.   
3.3.5 RNase H2A interacts with BRCA1, BRCA2 and RAD51 
Based on the observation that RNase H2A localizes to DSBs preferentially in S/G2 phase 
cells, we decided to monitor the extent of colocalization of RNase H2A with BRCA1 and 
RAD51. We observed a significant rate of colocalization of RNase H2A with both BRCA1 
(figure 38b) and RAD51 (figure 38c) in NCS treated cells. 
 
Figure 38: RNaseH2A colocalizes with BRCA1 and RAD51 in NCS-treated S phase cells 
a) Representative images of BRCA1 (cyan), RNase H2A (yellow), RAD51 (magenta) colocalization in NCS-
treated S phase U2OS cells. Dot plot represents the number of RNase H2A and either BRCA1 (b) and RAD51 
(c) colocalization in DMSO or NCS-treated S phase U2OS cells relative to random (>50 cells, n=3).  
 
Next, I planned to test whether RNase H2 colocalization with BRCA1 and RAD51 was a 
hint of an interaction between the two proteins. For this, I collaborated with Marek 
Adamowicz, a postdoc in our lab, who performed immunoprecipitation experiments of 
RNase H2A from cell lysates of HEK293T cells exposed or not to ionizing radiations. We 
observed that RNase H2A coimmunoprecipitates and thus interacts with BRCA1, RAD51 
γH2AX (cyan)/RNase H2A (magenta)
a b γH2AX-RNase H2A
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(figure 39a), BRCA2, and PALB2 (figure 39b), independently of DNA damage induction 
– these experiments were performed in the presence of benzonase, a nuclease that degrades 
all nucleic acids in the extract, thus excluding that this interaction was mediated by nucleic 
acids. Since BRCA1 is found in many different complexes upon damage, we tested whether 
RNase H2A interaction could also be observed in other BRCA1 complexes, including the 
BRCA1-A or BRCA1-C, as discussed in the introductory section “The multiple roles of 
BRCA1 in the DDR” and shown in figure 1. For this reason, we probed the RNase H2A 
immunoprecipitates for RAP80 and CtIP, two members of the BRCA1-A and BRCA1-C 
complex, respectively. As shown in figure 39c, no interaction with RAP80 and CtIP was 
observed. These results indicate that RNase H2A interacts with BRCA1 and RAD51 and 
that this complex formation is specific to the components of the BRCA1 complex involved 
in HR.    
 
Figure 39: RNase H2A interacts with BRCA1, BRCA2, and RAD51, but is not part of other BRCA1 
complexes 
Immunoblot analysis of the immunoprecipitations of RNase H2A in not irradiated or irradiated HEK293T 
cells. BRCA1, RAD51 (a), BRCA2, PALB2 (b), CtIP and Rap80 (c) were probed. (WCE-Whole cell extract). 
 
To determine which of the above proteins was directly binding to RNase H2A, we prepared 
cell lysates from cells depleted either of BRCA1 or RAD51 by siRNA transfection and we 
performed RNase H2A immunoprecipitations with them. We observed that, while BRCA1 
absence does not affect RNase H2A interaction with RAD51, the interaction of RNase H2A 
with BRCA1 is lost upon RAD51 depletion. This suggests that RNase H2A interacts with 
BRCA1 through RAD51 (figure 40).  
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Figure 40: RNase H2A interacts with BRCA1 through RAD51 
Immunoblot analysis of RNAse H2A immunoprecipitation in HEK293T cells depleted for BRCA1 or RAD51. 
(WCE-Whole cell extract). 
 
Next, in order to identify the domain of RAD51 responsible for the interaction with RNase 
H2A, we used sequential fragments of the RAD51 protein fused with the glutathione S-
transferase (GST) to perform GST-pulldowns in cells expressing YFP-tagged RNase H2A. 
We observed a specific interaction between recombinant RNase H2A and GST-RAD51 
fragment encoding for the middle portion of RAD51 (184-257aa). Additionally, we noticed 
a much weaker interaction with the 101-184aa and 257-337aa fragments (Figure 41).  
Altogether, these results show that RNase H2A interacts directly with RAD51 through the 
RAD51 region responsible for the interaction with BRCA2 and PALB2. Moreover, RNase 
H2A, through RAD51, also interacts with BRCA1 and BRCA2.  
 
Figure 41: GST pulldown reveals the RAD51 fragments interacting with RNase H2A 
Immunoblot analysis of GST pulldowns with sequential non-overlapping GST-RAD51 fragments. HEK293T 
cells were transfected with RNase H2A-YFP, lysed and used in the pull down experiment.  
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4 Discussion 
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4.1 The impact of DSB-induced RNAs and DNA:RNA hybrids on HR 
4.1.1 DSB-induced transcription: RNA joins the DNA damage world 
For years, DDR has been considered a proteins-only signaling cascade. However, recently, 
evidence supporting a role for RNA in this process has emerged. In 2012 our group and 
others reported the generation upon DSB of sncRNAs with the sequence of the damaged 
locus (Francia et al., 2012, Wei et al., 2012, Michalik et al., 2012). These RNA species, 
named DDRNAs and diRNAs, were reported to be involved in DDR signaling (Francia et 
al., 2012, Francia et al., 2016) and HR (Gao et al., 2014, Wei et al., 2012), respectively. Such 
damage-induced sncRNAs generation was reported to require RNAi proteins-mediated 
nuclease activities, thus suggesting the existence of a longer precursor transcript. 
The affinity of RNA pol II for DNA ends was known for several years (Dynan and Burgess, 
1981), but no physiological relevance was attributed to this observation. However, very 
recently our lab demonstrated in different in vivo and in vitro systems that the apical DDR 
protein complex MRN contributes to the recruitment of the transcriptionally active RNA pol 
II to exposed DNA ends upon damage (Michelini et al., in press). Upon DSB generation, 
RNA pol II-mediated bi-directional transcription from the DNA ends generates two RNA 
species, named dilncRNAs from (see figure 42). In addition, RNA pol II transcription toward 
the break generates other RNA species known as dilncRNAs to, at a lower extent compared 
to dilncRNAs from. dilncRNAs are processed by DROSHA and DICER to generate 
DDRNAs whose localization is mediated by their binding to the unprocessed 
complementary dilncRNA, via RNA:RNA interaction. Although the exact mechanism of 
DDRNAs function in DDR has not been fully understood, our lab demonstrated that 
DDRNAs promote DDR at least in part by associating with 53BP1 and mediating its 
recruitment to the damaged locus (Michelini et al., in press). However, whether the 
interaction is direct or it requires additional proteins or their modifications remains to be 
addressed.   
	 97	
 
                                                                        adapted from (Michelini et al., in press) 
Figure 42: DilncRNAs synthesis at DSBs 
Upon DSB, RNA pol II is recruited to the DNA ends. RNA pol II bi-directional transcription generates two 
different RNA species, named dilncRNAs from and dilncRNAs to. dilncRNAs are processed by DROSHA and 
DICER to produce DDRNAs, which localize at DSBs via RNA:RNA interaction with the precursors 
dilncRNAs and contribute to DDR activation.  
 
4.1.2 DSB-induced de novo transcription and DSB-induced silencing: a compromise 
exists.  
Although an increasing amount of evidence supports de novo transcription from sites of 
damage, the observation of damage-induced transcriptional silencing could seem in contrast 
with this (Shanbhag et al., 2010, Pankotai et al., 2012). Indeed, it has been observed that 
transcription of a reporter gene is inhibited via ATM-mediated chromatin condensation 
when a cluster of DSBs is generated in close proximity of the gene (Shanbhag et al., 2010). 
Additionally, RNA pol II exclusion from laser microirradiation sites has been observed (Beli 
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et al., 2012, Chou et al., 2010). DSB-induced de novo transcription and transcriptional 
silencing are clearly two distinct events but they are not mutually exclusive. It is important 
to note, for example, that, while DSB-induced transcriptional repression is ATM-dependent, 
dilncRNAs transcription is not affected by ATM inhibition (Michelini et al., in press). The 
observed RNA pol II depletion from sites of laser microirradiation is hard to interpret 
unambiguously since the low resolution of the canonical imaging techniques may not allow 
to discriminate between RNA pol II exclusion, associated with transcriptional inhibition, 
and DSB-induced RNA pol II recruitment, as we observed both by super-resolution imaging 
and ChIP (Michelini et al., in press). It is possible that DSB-induced de novo transcription 
and transcriptional silencing are temporally regulated: the first is an early event in DDR and, 
by promoting DDR and, in particular, ATM activation, may even contribute to RNA pol II 
exclusion from sites of damage, thus causing transcriptional silencing.   
4.1.3 DNA:RNA hybrids are formed at DSBs 
A possible consequence of RNA pol II transcription from DSBs is the generation of 
DNA:RNA hybrids. Although usually considered a by-product of cellular metabolism and 
one of the causes of genome instability, the role of DNA:RNA hybrids in several 
physiological processes has been recently appreciated (Aguilera and Gomez-Gonzalez, 
2017). For example, it has been shown that DNA:RNA hybrids control gene expression 
(Ginno et al., 2013, Ginno et al., 2012) and termination of transcription (Skourti-Stathaki et 
al., 2011, Skourti-Stathaki et al., 2014). Exposed DNA ends such as those generated upon 
DSB resection are potential templates for RNA pairing and, thus, DNA:RNA hybrids 
formation. DNA:RNA hybrids accumulation at DSBs has been recently described in 
Schizosaccharomyces pombe (Ohle et al., 2016). In human cells, DNA:RNA hybrids 
formation at DSBs has not been demonstrated yet, although some data seem to suggest it. It 
has been observed, for example, that catalytically inactive Escherichia coli RNase H, used 
as a tool to detect DNA:RNA hybrids, accumulates at laser micro-irradiation regions (Britton 
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et al., 2014). Moreover, it has been proposed that the human RNA-unwinding protein DEAD 
box 1 (DDX1) is recruited to DSBs possibly via DNA:RNA hybrids (Li et al., 2016). 
Although these data indirectly suggested DNA:RNA hybrids formation upon DNA damage, 
a better characterization of the process that may lead to their formation was still missing. It 
was not clear, for example, whether the DNA:RNA hybrids observed upon damage where 
the result of de novo transcription, according to the recent model of damage-induced RNA 
pol II transcription from the broken DNA ends (Michelini et al., in press) (see figure 42), or 
were the result of pairing of pre-existing transcripts to a more open and easily accessible 
DNA template generated upon damage. Here, I document DNA:RNA hybrids formation at 
DSBs by independent imaging techniques and DNA:RNA hybrids immunoprecipitation 
(DRIP). More specifically, I show DNA:RNA hybrids accumulation at a damaged repetitive 
exogenous site integrated within the genome by immunofluorescence with the S9.6 
antibody; I observe an increase in DNA:RNA hybrids levels in the nucleus of irradiated 
cells, as detected by a GFP-tagged catalytically inactive RNase H1 expressed in cells lacking 
the endogenous one; I also describe DNA:RNA hybrids accumulation at DSBs in two 
different cellular systems (I-PpoI or AsiSI endonucleases expressed in different cell lines) 
at genic and inter-genic regions, by performing DRIP with the S9.6 antibody. Importantly, 
the observation that DNA:RNA hybrids accumulate upon damage at DSBs located in non-
genic regions excludes the possibility that damage-induced DNA:RNA hybrids are the result 
of the annealing of pre-existing transcripts with the template DNA. It seems, instead, that 
these hybrids are the result of the hybridization of dilncRNAs with the damaged template 
DNA. Similarly to dilncRNAs, DNA:RNA hybrids do not accumulate at DSBs when RNA 
pol II transcription is acutely inhibited, thus confirming that they are the result of RNA pol 
II-mediated de novo transcription. The possibility that DNA:RNA hybrids are the result of 
DDRNAs hybridization to the template DNA can be excluded since we observed that 
DDRNAs localization to DSBs is not affected by RNase H1 overexpression (Michelini et 
al., 2017).  
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4.1.4 DSB-induced DNA:RNA hybrids form preferentially in S/G2 phase cells on resected 
DNA ends 
Since the accessibility of the template DNA is a crucial step in DNA:RNA hybrids 
formation, it is likely that damage-induced DNA:RNA hybrids form preferentially during 
the S/G2 phase of the cell cycle, when resected DNA ends are available. In yeast, although 
not supported by experimental data, it has been proposed that DNA:RNA hybrids are 
generated at DSBs by pairing of RNA species to the resected DNA ends (Ohle et al., 2016). 
Our results obtained by DRIP in G1 and S/G2 cells and by immunofluorescence analyses 
with canonical and super-resolution microscopy reveal that damage-induced DNA:RNA 
hybrids accumulate preferentially in the S/G2 cell cycle phase, when they colocalize with 
HR proteins including BRCA1 and RAD51. DRIP experiments in cells depleted of CtIP, a 
key protein in DNA end resection, further confirm the hypothesis that DNA:RNA hybrids 
accumulate only on resected DNA ends and reveal indeed a strong decrease in damage-
induced DNA:RNA hybrids accumulation upon CtIP depletion. However, it is known that 
CtIP interacts with MRN to promote DNA end resection (Sartori et al., 2007) and we 
reported that MRN activity is required for dilncRNAs generation (Michelini et al., in press).  
Therefore, it cannot be excluded that the reduction of DNA:RNA hybrids levels at DSBs 
upon CtIP depletion is caused by impaired MRN activity, which in turn results in lower 
dilncRNAs synthesis. In order to further confirm the impact of DNA end resection on 
DNA:RNA hybrids formation at DSBs, I plan to monitor DNA:RNA hybrids levels at DSBs 
upon EXO1 depletion, an exonuclease which only acts in the later steps of DNA end 
resection and does not impact on the early steps of the process.  
In line with the hypothesis that DNA:RNA hybrids form on the resected DNA ends, the 
DNA:RNA hybrids-dependent recruitment of the RNA-unwinding protein DDX1 to DSBs 
has also been reported to be dependent on DNA end resection (Li et al., 2016). The 
possibility that DNA:RNA hybrids stronger detection in S/G2 is due to an increase of their 
processing and degradation in G1 phase is unlikely since G1 exposed DNA ends may not be 
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as good a template for RNA pairing as resected and easily accessible DNA ends. In addition, 
the recruitment of RNase H2 to S/G2 phase damaged cells, as discussed below, 
independently supports the notion of DNA:RNA hybrids accumulation in this specific cell 
cycle phase. The observation that DNA:RNA hybrids accumulation is regulated by DNA 
end resection also suggests that the dilncRNAs forming DNA:RNA hybrids likely are 
“dilncRNAs from” RNAs, that are complementary to the resected DNA ends.  
4.1.5 A new connection between DNA:RNA hybrids and DSB repair 
Once established that DNA:RNA hybrids form at DSBs, it remains to be elucidated what is 
their function. It is known that RAD51 mediates DNA:RNA hybrids formation in yeast RNA 
processing mutants (Wahba et al., 2013). On the contrary, it has been shown that DNA:RNA 
hybrids accumulate in BRCA1 and BRCA2 depleted cells (Bhatia et al., 2014, Tan et al., 
2017). This is in line with the model I propose in which BRCA2 recruits the RAD51-RNase 
H2 complex to DSBs to degrade DNA:RNA hybrids. The increased DNA:RNA hybrids 
level observed by Bhatia et al. in  BRCA1 and BRCA2 depleted cells could be caused by 
the inability of RNase H2 to recognize and degrade DNA:RNA hybrids formed at 
endogenous DSBs. Overall, the impact of HR proteins on DNA:RNA hybrids levels suggests 
a strong link between these proteins and DNA:RNA hybrids metabolism. It has been shown, 
for example, that DNA:RNA hybrids accumulation upon DDX1 depletion impairs HR in the 
DR-GFP system (Li et al., 2016). Conversely, in yeast, a tight regulation of DNA:RNA 
hybrids level at DSBs seems to be necessary for HR since excessive or insufficient 
DNA:RNA hybrids levels have been reported to negatively affect this repair phatway (Ohle 
et al., 2016). Recent data also suggest a role for SENATAXIN in DNA repair (Becherel et 
al., 2013, Yuce and West, 2013). SENATAXIN prevents transcription-associated 
DNA:RNA hybrids accumulation (Mischo et al., 2011) and in yeasts it associates with 
replication forks and protects their stability when they encounter highly transcribed genes 
(Alzu et al., 2012). It has been shown in mice that SENATAXIN facilitates meiotic 
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recombination (Becherel et al., 2013) and in human cells, it forms transcription- and 
DNA:RNA hybrids-dependent DNA damage foci in S/G2 phase, when it colocalizes with 
DDR proteins, including 53BP1 and BRCA1 (Yuce and West, 2013). Although a clear 
picture has not been yet drawn, all these findings support a role for DNA:RNA hybrids in 
HR. 
4.1.6 The role of DSB-induced RNA in HR 
The observation that RNA is necessary for the recruitment of HR proteins to DSB suggests 
a role for DNA:RNA hybrids in this process. Here, I show that inhibition of RNA pol II 
transcription impairs BRCA1, BRCA2, and RAD51 foci formation upon DSB. Interestingly, 
impaired RAD51 recruitment to DSBs is not caused by defective DNA end resection, since 
the efficiency of this process is mildly increased upon transcriptional inhibition. The 
observed proficient resection in the absence of BRCA1 recruitment may appear 
controversial, since BRCA1 modulates DNA end resection by interacting with CtIP. 
However, it has been shown that BRCA1-CtIP interaction is dispensable for resection 
(Reczek et al., 2013) and BRCA1 mainly controls this process by counteracting the 
inhibitory effect of 53BP1 (Escribano-Diaz et al., 2013). Upon transcriptional inhibition 
53BP1 recruitment to DSBs is inhibited as much as BRCA1 recruitment (Michelini et al., in 
press). As a consequence, in the absence of both 53BP1 and BRCA1, DNA end resection is 
likely to be proficient. Indeed, the undiminished number of RPA and P-RPA Ser4/8 foci 
detected by immunofluorescence upon transcriptional inhibition is consistent with that and 
their actual increase may be caused by either a higher efficiency of the process, or, more 
likely, by an increased availability of the ssDNA strand for the single-strand DNA binding 
protein RPA, since no complementary RNA species are transcribed. Similarly, detection of 
BrdU on ssDNA, as measured by native staining, may be masked by the presence of a 
DNA:RNA hybrid and thus transcriptional inhibition may improve its detection. Increase of 
the BrdU signal upon RNase H treatment in damaged cells could confirm this hypothesis.  
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Potential applications of ASOs-mediated HR inhibition  
The involvement of dilncRNAs in HR is further confirmed by the observation that ASOs 
matching and inhibiting the function of dilncRNAs potentially forming in the DR-GFP 
system inhibit homologous recombination (HR)-mediated repair. HR and single strand 
annealing (SSA) are two pathways that exploit sequence homology to repair damaged DNA, 
as described in the paragraph “HDR” of the introduction. Once broken DNA ends are 
resected, HR-mediated repair occurs via RAD51-mediatd invasion of the homologous 
sequence, while SSA anneals two homologous sequences exposed on the resected DNA ends 
through RAD52, with the consequent loss of genetic material. Interestingly, treatment of 
TRI-DR-U2OS cells with ASOs matching either dilncRNAs from or to only impairs HR, 
while not significantly affecting SSA, thus confirming that dilncRNAs are necessary for HR 
proteins recruitment to the DSBs and not for the DNA end resection step of the HDR-based 
pathways. It is possible to envision that ASOs treatment, as well as transcriptional inhibition, 
affects BRCA1 and RAD51 recruitment to DSBs thus impairing HR-mediated repair. The 
impact of ASOs treatment on recruitment of HR factors should be checked to confirm this 
hypothesis. According to the previously discussed role of BRCA1 in controlling DNA end 
resection, it would be expected that impaired BRCA1 localization to DSBs would also 
impact on DNA end resection. On the contrary, I observe that SSA is efficient upon ASOs 
treatment. Since others in the lab observed that ASOs treatment inhibit 53BP1 recruitment 
to DSBs (Michelini et al., in press), the same reasoning applied for the results obtained upon 
transcriptional inhibition can be useful to interpret these results. In brief, since BRCA1 
mainly controls DNA end resection by counteracting the barriers posed by 53BP1 to this 
process, in the absence of both 53BP1 and BRCA1, DNA end resection efficiency, and 
consequently SSA, is not affected. 
The observation that HR is inhibited upon treatment with ASOs matching either dilncRNAs 
from or to supports the idea that dilncRNAs control this process through a complex and 
multi-layered mechanism. It is known already that diRNAs, RNA species similar to 
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DDRNAs, control HR by acting on BRCA1 and RAD51 recruitment to DSBs (Gao et al., 
2014, Wang and Goldstein, 2016). Similarly to DDRNAs, diRNAs are generated by 
processing of a longer precursor transcript. By targeting dilncRNAs from and to, ASOs 
inhibit DDRNAs biogenesis. Additionally, they may also directly inhibit DDRNAs function, 
thus inhibiting HR by impairing the recruitment of HR proteins to the DSB.   
ASOs are becoming a widely used tool to block the functions of RNA molecules, including 
ncRNAs (McClorey and Wood, 2015) and they were recently used in our lab to inhibit DDR 
at site-specific loci (Michelini et al., in press), including telomeres in cultured cells and in 
mice (Rossiello et al., 2017). HR modulation by ASOs may be a powerful tool with several 
applications. Although inhibiting repair of a single DSB may not kill the cells, it is possible 
that cell death could be achieved by inhibiting repair of several DSBs with a known 
sequence. This is the case of oncogene induced fragile sites, whose sequence can be mapped, 
thus allowing inhibition of DDR and HR-repair by treatment with complementary ASOs. It 
could also be conceived that restriction enzymes selectively targeted to tumor cells and 
treatment with sequence-specific ASOs could allow DDR and HR-inhibition in these cells, 
thus resulting in tumor cells death.  
4.1.7 RNA and DNA:RNA hybrids mediate BRCA1 recruitment to DSB 
The specific role of RNA in HR is further confirmed by the observed disruption of BRCA1 
foci upon RNase A treatment of irradiated cells, which degrades both RNAs and DNA:RNA 
hybrids in the experimental conditions used. Further confirming the contribute of DNA:RNA 
hybrids in BRCA1 recruitment to DSBs, BRCA1 foci are also dismantled upon RNase H 
treatment. Persistency of RPA foci upon treatment with RNase A and RNase H not only 
demonstrates the specificity of the treatment, but confirms the results obtained with RNA 
pol II inhibitors and ASOs treatment. Impaired BRCA1 recruitment is also observed upon 
RNase H1 overexpression. Moreover, in vitro BRCA1 and the BRCA1-BARD1 constitutive 
heterodimer bind DNA:RNA hybrids even with higher affinity compared to dsDNA, thus 
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strengthening the idea that BRCA1 recruitment to DNA lesions may be facilitated by 
DNA:RNA hybrids formation. A similar scenario has been already envisioned by a recent 
publication suggesting DNA:RNA hybrids-mediated BRCA1 recruitment to the termination 
site of the β-actin gene where it recruits, in turn, SENATAXIN, thus suppressing DNA:RNA 
hybrids associated genome instability (Hatchi et al., 2015). The link between BRCA1 and 
transcription has been known since long time. The interaction between BRCA1 and RNA 
pol II and its ability to modulate transcription was known since the 90ies (Scully et al., 1997, 
Chapman and Verma, 1996, Anderson et al., 1998, Neish et al., 1998) and recent data further 
strengthen this link by showing, for example, that BRCA1 recognizes miRNA precursor and 
promotes their processing by interacting with DROSHA (Kawai and Amano, 2012). 
Given the impact of transcription inhibition, RNase A and RNase H treatment on focal 
accumulation of HR factors, and the decreased HR efficiency upon ASOs treatment, it can 
be concluded that dilncRNAs control HR, in part by modulating BRCA1 recruitment to 
DSBs via DNA:RNA hybrids formation. The complete abrogation of BRCA1 focal 
accumulation at DSBs upon transcriptional inhibition compared to the moderate reduction 
observed upon RNase H treatment and RNase H overexpression, further suggests that RNA 
pol II-mediated transcription controls BRCA1 recruitment through several redundant 
pathways. As already mentioned for ASOs treatment, it is possible that DDRNAs contribute 
to this process (Gao et al., 2014, Wang and Goldstein, 2016). Moreover, the possibility that 
BRCA1 recruitment to DSBs is controlled by direct interaction with RNA pol II cannot be 
excluded. It is possible that the residual BRCA1 recruitment upon RNase H overexpression 
is sufficient to mediate RAD51 recruitment and HR. Another possibility is that RNase H 
overexpression only delays BRCA1 loading and this can be the reason why no defect in 
RAD51 loading to DSBs and HR-mediated repair is observed upon RNase H 
overexpression.  
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4.2 RNase H2: a new player in DSB repair  
While a certain level of DNA:RNA hybrids at DSBs may promote repair by facilitating 
BRCA1 recruitment, it is also possible that accumulation of these hybrids may negatively 
affect DSB repair. It has already been reported in a recent paper that accumulation of 
DNA:RNA hybrids at the DR-GFP locus in human cells impairs HR (Li et al., 2016). In line 
with these results, it has been demonstrated in human and drosophila cells that 
EXOSC10/RRP6, the catalytic component of the RNA exosome with a 3’ to 5’ 
exoribonuclease activity (Houseley et al., 2006), localizes to DSBs, interacts with RAD51, 
and its activity is required for RAD51 loading to DSBs, although no impact on DNA end 
resection has been tested (Marin-Vicente et al., 2015). Yeast Rrp6 is necessary for RPA, but 
not RAD51, loading on resected ssDNA ends (Manfrini et al., 2015). Although the two 
observations do not fit perfectly, they support the idea that in the absence of RRP6, excessive 
RNA and, possibly, DNA:RNA hybrids accumulation at DSBs inhibit the loading of RPA 
and RAD51 on the resected DNA ends. However, in yeast Rrp6 mutants defective RPA 
loading is not restored by RNase H1 overexpression (Manfrini et al., 2015). Differently, at 
telomeres, DNA:RNA hybrids seem to favor HR: RNase H1 has been shown to regulate 
TERRA DNA:RNA hybrids at telomeres that uses ALT, an HR-based telomere elongation 
mechanism (Arora et al., 2014); in yeast, increased DNA:RNA hybrids caused by impaired 
RNase H2 localization, favors telomere elongation (Graf et al., 2017). In yeast, only a certain 
level of DNA:RNA hybrids at DSBs facilitates DSB repair: too many hybrids inhibit RPA 
binding on the resected DNA ends; on the other hand, lack of hybrids allows excessive 
resection and inhibit HR because other pathways, such as SSA, are preferred (Ohle et al., 
2016). For this reason, DNA:RNA hybrids levels at the damaged loci must be tightly 
regulated. At the cellular level, control of DNA:RNA hybrids level is continuously 
guaranteed by either avoiding DNA:RNA hybrids formation, through binding of nascent 
RNA with RNA binding proteins, or by resolution or degradation of already formed hybrids 
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by helicases like SENATAXIN, and RNase H enzymes, respectively. In eukaryotic cells, 
DNA:RNA hybrids are degraded by RNase H1 and RNase H2, a trimeric protein composed 
of RNase H2A, B, and C subunits (Cerritelli and Crouch, 2009). In particular, RNase H2 has 
already been shown to resolve DNA:RNA generated by RNA polymerases during 
transcription (El Hage et al., 2010, Lin et al., 2010).  
4.2.1 RNase H2 depletion impacts on HR by reducing HR proteins levels   
Yeast mutants for the cellular RNase H enzymes show decreased HR levels (Ohle et al., 
2016). In our case, depletion of either RNase H1 or RNase H2 to study the impact of 
DNA:RNA hybrids accumulation on HR could not be used: while RNase H1 knock-down 
could not be obtained with the tools available in the lab, RNase H2 depletion reduced the 
levels of key HR proteins. Although this result did not allow us to recapitulate in our hands 
the impact of DNA:RNA hybrids accumulation on HR, it revealed a new layer of control of 
this pathway by RNase H2, possibly through DNA:RNA hybrids accumulation. Indeed, in 
the last few years DNA:RNA hybrids have emerged as regulators of gene expression 
(Skourti-Stathaki and Proudfoot, 2014). It is possible, therefore that expression of HR genes 
is modulated by DNA:RNA hybrids and aberrant DNA:RNA hybrids accumulation, caused 
by RNase H2 depletion, could impact on expression of those genes. This could be a 
mechanism that cells have evolved to push repair toward NHEJ in the absence of a key 
enzyme responsible for removal of DNA:RNA hybrids that would impede, when too many, 
HR repair. Moreover, it could also be possible that the reduced expression of HR proteins in 
the absence of RNase H2 is the result of a feedback mechanism that controls the expression 
of components of the same complex to keep the right stoichiometry. For example, feedback 
regulation of gene expression at the post-transcriptional level is common. There are 
examples of ribosomal and RNA-binding proteins which repress their translation by binding 
their mRNAs (Philippe et al., 1993, Dabeva and Warner, 1993, Boelens et al., 1993). 
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Another example is the negative regulation of DGCR8 expression by the Drosha-DGCR8 
complex through cleavage of DGCR8 mRNA (Han et al., 2009). 
4.2.2 RNase H2 joins BRCA2 and RAD51  
The formation of DNA:RNA hybrids at DSBs and the requirement of a tight regulation of 
their levels suggest that proteins involved in DNA:RNA hybrids resolution could localize to 
DSBs. It has already been shown that the human RNA-unwinding protein DDX1 (Li et al., 
2016) and the DNA/RNA helicase SENATAXIN (Yuce and West, 2013) localize to DSBs 
in S/G2 phase cells in a transcription- and DNA:RNA hybrids-dependent way. Here we show 
by ChIP analysis, PLA, and super-resolution microscopy that RNase H2A, which accounts 
for the major RNase H activity in mammalian cells, is recruited to DSBs. In line with the 
cell-cycle regulation of DNA:RNA hybrids accumulation, RNase H2A localization to DSBs 
is limited to the S/G2 cell cycle phase, despite its level does not change throughout the cell 
cycle phases as shown here and in mouse cells (Reijns et al., 2012). In S/G2 damaged cells, 
RNase H2 colocalizes with the HR proteins BRCA1 and RAD51 through direct interaction 
with RAD51. Immunoprecipitation of the endogenous RNase H2A indeed reveals 
interaction with BRCA1, BRCA2, and RAD51, but not with RAP80 and CtIP, which form 
with BRCA1 the BRCA1-A and the BRCA1-C complexes, respectively. The direct 
interaction of RNase H2A with RAD51 has been shown by RNase H2A 
immunoprecipitation on cells depleted for BRCA1 and RAD51: in the absence of BRCA1 
RNase H2A-RAD51 interaction is kept, while in the absence of RAD51 BRCA1-RNaseH2A 
interaction is lost. From this result it can also be inferred that the binding of RNase H2A 
with RAD51 is not mediated by BRCA2. Indeed, in the context of RAD51 depletion BRCA2 
would still bind both RNase H2 and BRCA1, therefore the BRCA1-RNAse H2 indirect 
interaction would have not been lost, as we see instead. GST-pulldowns using GST 
fragments of the entire RAD51 proteins further confirm the specificity of RNase H2A-
RAD51 interaction. Moreover, the GST-pulldown not only provides evidence of the specific 
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RNase H2A-RAD51 interaction, but also allows to exactly localize the RNase H2 interaction 
domain in the RAD51 fragment already involved in BRCA2 and PALB2 binding. RAD51-
mediated RNase H2 recruitment to DSBs would allow the degradation of the DSB-induced 
DNA:RNA hybrids in the later steps of HR, when DNA:RNA hybrids are not anymore 
needed, thus facilitating RAD51 loading on the ssDNA ends. This model could also explain 
the recently emerging link between BRCA1, BRCA2 and DNA:RNA hybrids. However, 
since the DNA:RNA hybrids accumulation in BRCA1 and BRCA2 depleted cells is not cell-
cycle dependent and is not observed upon RAD51 depletion, it is possible that BRCA2 
favors DNA:RNA hybrids resolution through two distinct mechanisms: in undamaged cells, 
it recognizes the branched structures in R-loops, that are similar to the replicative 
intermediates to which it binds (Lomonosov et al., 2003, Schlacher et al., 2011) and exposes 
the DNA:RNA hybrids to further processing by other factors (Bhatia et al., 2014); in 
damaged cells, BRCA2 recruits RAD51 and RNase H2, thus directly contributing to 
DNA:RNA hybrids degradation. The effect of BRCA2 and RAD51 depletion on DNA:RNA 
hybrids level at DSBs will finally prove whether RAD51-mediated RNase H2 recruitment 
to DSBs is needed for DNA:RNA hybrids degradation. The discrepancy between the 
observation that RAD51 favors DNA:RNA hybrids formation in RNA processing mutants 
in yeast (Wahba et al., 2013) and our results could be explained by a different role of RAD51 
at damaged and undamaged loci, although we observe that RAD51 binding with RNase H2 
is independent of DNA damage induction.  
4.2.3 A possible link between RNase H2 activity and AGS  
RNase H2 mutations are associated to the neuroinflammatory AGS syndrome, which 
pathogenesis is possibly associated to an excessive inflammatory response due to the 
accumulation of DNA:RNA hybrids (Crow et al., 2006). RNase H2 mutant mice are not 
viable and an increased genome instability and DNA-damage response is observed during 
the early embryogenesis (Reijns et al., 2012). This phenotype has been associated to 
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ribonucleotides incorporation in the genome, although the possibility that DNA:RNA 
hybrids accumulate in these embryos has not been excluded. Interestingly RNase H2 is 
expressed globally during embryogenesis and mainly in the highly proliferative cells in 
adults (Reijns et al., 2012). Highly proliferating cells are the ones that have a higher chance 
to incorporated ribonucleotides during DNA replication, but they are also the ones that can 
undergo repair by HR and both are good reasons for a cell to express high levels of RNase 
H2. It is possible, therefore, that the genome instability observed in the RNase H2 null mice 
is not only caused by ribonucleotides incorporation, but also by impaired HR-mediated 
repair. As a consequence of this speculation, stimulating repair by NHEJ in cells lacking the 
RNase H activity could be a strategy to partially reduce genome instability in these cells. 
Inhibition of MRN endonuclease activity has been shown to inhibit DNA end resection and 
HR (Shibata et al., 2014). It could be concluded, therefore, that using this inhibitor in AGC 
cells could at least reduce the genomic instability associated to HR defects.  
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4.3 A model of the sequence of events occurring at DSBs   
 In conclusion, from the results discussed above the following working model can be 
proposed (figure 43). Upon DSB generation, RNA pol II binds to the DNA ends and 
transcribes dilncRNAs from and to (Michelini et al., in press) (figure 43a and b). Pairing of 
dilncRNA from and to forms dsRNAs that are cleaved by DICER to generate DDRNAs. 
Hairpin secondary structures possibly present in the dilncRNAs may require an additional 
DROSHA-mediated cleavage step for DDRNAs production (figure 43c). DDRNAs 
contribute to DDR focus formation and signaling and consequently to HR, as already 
reported by several authors (Wang and Goldstein, 2016, Gao et al., 2014, Wei et al., 2012). 
If then DNA end resection takes place, dilncRNAs from can match the 3’ protruding DNA 
end, thus forming a DNA:RNA hybrid (figure 43d). In principle, DNA:RNA hybrids 
formation could favor antisense transcription (dilncRNAs to), as already proposed at gene 
terminators (Skourti-Stathaki et al., 2014). However, this needs to be reconciled with the 
observation that DNA:RNA hybrids form by hybridization of the dilncRNA from with the 
3’ protruding DNA end (Figure 43 d). At this step, the 5’ protruding end which should be 
used as a template for synthesis of dilncRNAs to should have been already degraded. 
 DNA:RNA hybrids formed on the resected DNA ends contribute to BRCA1 recruitment 
which, in turn, recruits other HR proteins, including BRCA2 and RAD51. Through direct 
binding with RAD51, RNase H2 localizes to DSB during S/G2 phase, where it probably 
degrades DNA:RNA hybrids, thus allowing RAD51 loading and HR completion.  
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Figure 43: Hypothetical sequence of events occurring at DSBs  
RNA pol II transcription at DSBs generates dilncRNAs from and to. a) Hybridization of dilncRNAs from and 
to mediates the formation of dsRNAs that are processed by DICER to generate DDRNAs. RNA hairpin 
secondary structures may require an additional processing step mediated by DROSHA to produce DDRNAs. 
b) When DNA end resection takes place, less template for dilncRNA to synthesis is available and dilncRNA 
from hybridize to the exposed resected DNA ends. DNA:RNA hybrids recruit BRCA1, which, in turn, 
promotes their degradation via RAD51-mediated RNase H2 recruitment. Possibly, RNase H2A degrades the 
DNA:RNA hybrids, thus allowing RAD51 loading and HR.  
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